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Abstract
The Human Leukocyte Antigen (HLA) gene system is the most polymorphic region
of the human genome, containing some of the strongest associations with autoimmune,
infectious, and inflammatory diseases. It plays a crucial role in hematopoietic stem
cell transplantation, where patients and donors are matched with respect to their HLA
genes to maximize the chances of a successful transplant. As such, HLA data is a highly
valuable asset for clinicians and researchers for elucidating various disease-driving bio-
logical mechanisms. This thesis contains original research on the analysis of uncertainty
in HLA data, exploration of the strong correlation structure in the region and prediction
of HLA genes from widely available genetic markers.
We start by describing a novel method for correlated multi-label, multi-class predic-
tion, which aims to solve the problem of prediction of HLA genes from widely available
Single Nucleotide Polymorphism (SNP) data. Direct typing of HLA genes for large
studies is expensive due to their extreme genetic polymorphism. Therefore, obtaining
the HLA genes by prediction, rather than genetic typing, would be highly time- and
cost-effective. In this study we use a two-step approach, involving label (gene) inde-
pendent classifiers and label dependencies in the form of HLA haplotype frequencies, to
predict HLA genes from SNP data. In addition, we propose different ways of integrating
label dependency information into the prediction process and evaluate their impact on
the prediction performance. The results from experiments on real-world data sets show
that adding label dependencies into the prediction of HLA genes increases prediction
accuracy when compared against the gene-independent approach.
Next, we aim to resolve and quantify the uncertainty that exists in HLA data sets.
Due to the high genetic polymorphism of HLA genes, their molecular typing often results
in a set of uncertain or ambiguous assignments, rather than an exact allele assignment at
each gene. We propose a novel, information theoretic measure to quantify uncertainty
in HLA typing. In addition, we demonstrate that using the HLA gene dependencies
that reflect the strong correlation structure in the region, decreases the uncertainty in
HLA data.
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In the fourth chapter of the thesis, we propose a novel approach for multi-label
prediction from uncertain data in the context of SNP-based prediction of HLA genes
using ambiguous HLA data in training. Most existing HLA data sets contain uncer-
tainty and, as such, need to be imputed to exact data before being used for training
prediction models. Existing approaches for prediction of HLA genes from SNP data do
not accommodate learning from uncertain data and, as such, miss the potential for an
increased sample size and consequently improvements in prediction performance. In this
thesis, we propose a novel algorithm for SNP-based prediction of HLA genes that uti-
lizes ambiguous HLA data for building the prediction model. Additionally, we measure
the impact that the uncertainty in the training data has on the prediction accuracy,
and evaluate it on a real world data set. Our results show that the prediction from
ambiguous HLA data generally performs better than the alternative approach which
first imputes the ambiguous data into high-resolution HLA alleles and uses it to build
the model.
The work in this thesis is a step toward understanding the immense challenges in
the analysis of the HLA gene system. In this thesis, we: i) define and solve a problem of
prediction of HLA genes from widely available genetic markers using a correlated multi-
label, multi-class approach, ii) define and validate a measure to quantify the uncertainty
present in HLA data sets, and iii) propose a novel approach to correlated prediction
from uncertain data in the context of prediction of HLA genes. We conclude the thesis
by discussing future work to further the understanding of this important genetic region
through novel computational algorithms.
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Chapter 1
Introduction
1.1 Background
1.1.1 Human leukocyte antigen genes
The Human Leukocyte Antigen (HLA) gene system on chromosome 6, also known as the
Major Histocompatibility Complex (MHC) region, is the most polymorphic region of the
human genome and one of the most extensively studied regions due to its importance in
transplantation and association with autoimmune, infectious and inflammatory diseases
[14, 16]. The HLA region contains genes that encode proteins crucial for adaptive
immune response, and its high genetic polymorphism allows the immune system to fight
a variety of adversities. This gene system plays a critical role in hematopoietic stem cell
transplantation (HSCT), where patients and donors are matched with respect to their
HLA genes in order to maximize the chances of a successful transplant [19]. HLA genes
that are most intensively studied are the so-called classical HLA genes divided into two
regions: class I (HLA-A, -B, -C) and class II (HLA-DR, -DQ, -DP) as shown in Figure
1.1.
The HLA genes are highly polymorphic - there are many variations of these genes
in a population. We refer to variations of the genes as alleles. Developments in DNA-
based typing methods have seen a large increase in new HLA alleles being identified
each year with an average rate of over one new allele discovered per day [38, 72]. As
of today, more than 9, 000 alleles have been discovered for the class-I, HLA-A, -C, -B,
1
2Figure 1.1: Human leukocyte antigen (HLA) gene system on chromosome 6. Shown are
the genomic locations of 6 HLA genes, HLA-A, -C, -B, -DR, -DQ, -DP.
and class II, HLA-DRB1, -DQB1 genes [64]. The chance of two unrelated individuals
having identical HLA alleles on all genes is very low since the diversity of HLA in the
human population is one aspect of disease defense.
Naming of HLA alleles is standardized and regulated by the World Health Organi-
zation Nomenclature Committee for Factors of the HLA System [40]. Each allele starts
with the gene name (e.g., A, B, DRB1, etc.), followed by at least two sets of digits,
separated by colons (Figure 1.2). The first set of digits corresponds to the serological
antigen encoded by the allele, while the second one corresponds to a specific subtype.
For example, allele A ∗ 01 : 02 is found on gene A, belongs to 01 allele group and en-
codes a protein coded as 02. If necessary, longer names are assigned up to a total of four
sets of digits. Two-digit resolution, also referred to as allele-family level, groups alleles
into functionally related categories and is not protein-specific. In stem cell transplants,
patients and donors are matched with respect to their four-digit alleles, since they iden-
tify the exact protein product of the gene. This resolution is commonly referred to as
high-resolution.
1.1.2 Uncertainty (ambiguity) in HLA data
The high polymorphism in HLA presents a challenge when it comes to typing or sequenc-
ing HLA genes. The typing has historically been performed using serological antibody
tests, which are able to identify HLA protein variants on the surface of the cell using
3Figure 1.2: HLA allele naming [63]
antigen-specific antibodies [9]. Serology has been widely replaced with DNA-based typ-
ing methods due to its inability to identify all specific variations of the HLA alleles. It
has been shown that in order to improve the clinical outcome of stem cell transplanta-
tion from an unrelated donor, it is essential to identify and match patient and donor’s
HLA genes at the allele level [75, 46, 57, 66].
DNA-based methods identify HLA alleles by interrogating the nuclear DNA sequence
and can result in different levels of ambiguity depending on typing methodology or test
kits used. HLA typing methods, their corresponding formats and abbreviations are
shown in Table 3.1. Some of the widely used molecular methods for typing HLA genes,
as defined in American Society for Histocompatibility and Immunogenetics Standards
(ASHI), are a nucleic acid-based typing method using sequence-specific oligonucleotide
hybridization (SSO) [25, 48], a nucleic acid amplification-based typing method using
sequence-specific priming (SSP) and sequence-based typing (SBT) [65]. Even though
DNA-based technology improved identification of specific alleles, HLA typing results re-
ported by testing laboratories are still commonly resolved to a certain level of ambiguity,
rather than to an exact allele assignment [23]. Exact high resolution HLA typing can
be costly and laborious with the large and rapidly growing number of described HLA
alleles, which sometimes cannot be easily distinguished with existing high-throughput
typing methods. Ambiguous allele assignments are produced either due to failure to
interrogate all polymorphic positions, or due to a lack of phase between polymorphisms
4within a gene because of diploid sequence reads (or both).
In HSCT the selection of donors for a patient in need of a transplant is based
primarily on HLA matching, and the lower the ambiguity of typing the easier it is to
determine the probability of allele level match during the donor search [26]. In order
to facilitate rapid identification of matched donors for HSCT several methods have
been proposed to infer unknown phase and allele assignment [19, 35]. They typically
employ statistical methods and the unique properties of the HLA region, such as its
high linkage disequilibrium, in order to estimate haplotype frequencies and predict the
most likely haplotype assignment for an individual with an HLA typing consisting of a
set of ambiguous allele pairs. HLA typing with less ambiguity on average gives fewer
high-probability phased high resolution haplotypes. Resolving the uncertainty in HLA
data is important to all its relevant downstream uses.
1.2 Thesis Contributions
1.2.1 Correlated prediction of HLA genes from SNP data
Direct typing of HLA alleles for large studies is prohibitively expensive. It is estimated
that typing of HLA alleles of class I and class II genes is about as expensive as typ-
ing 500,000 single nucleotide polymorphisms (SNPs), mostly bi-allelic genetic markers,
across the genome [32]. However, HLA genes could be a causal or confounding factor in
large studies due to their strong disease associations [14, 16] and some of the strongest
adverse drug reactions [42, 41]. Previous studies have shown that single nucleotide
polymorphisms and other genetic markers show strong associations with HLA alleles
[11, 39]. This finding motivated work in the area of HLA prediction from SNP geno-
types with the goal of enriching available large genome-wide studies with this valuable
information. These methods have been successfully applied on SNP data sets to infer
HLA genes and demonstrated the ability to confirm known drug and disease associations
found in HLA-based studies using SNP data only [10, 42].
Initial attempts in HLA inference from SNP data used tag SNPs to infer common
HLA alleles [11]. This study observed that there is a strong association (linkage dise-
quilibrium (LD)) [13] between genetic markers and some HLA alleles and listed several
such associations. While the study demonstrated efficient prediction of some common
5HLA alleles using one or two SNP markers, this approach does not provide a solution for
accurate prediction of all HLA alleles due to their high polymorphism and the existence
of many rare alleles, which are hard to predict using a small number of tag SNPs.
More sophisticated methods have since been developed and used to predict HLA
alleles from SNP data. These methods can be roughly divided into two categories:
i) methods that use phased1 SNP haplotypes to predict HLA alleles [32, 70, 43] and
ii) methods that use un-phased SNP genotypes to predict HLA alleles [34, 12, 85,
27]. Empirical evaluation of known issues in HLA prediction is described in [84] and
demonstrated with the methods in [34] on several datasets of different ancestries and
different typing methodologies.
All existing approaches make predictions for HLA alleles for each gene independently.
They consider each HLA gene as an independent label and build predictive models with
respect to each label separately. Since many HLA alleles are known to be in strong
linkage disequilibrium [13], we recently described an approach that takes advantage
of this label dependency to assist the HLA inference. For example, we might predict
an individual’s HLA-C allele with high confidence, but not the HLA-B allele since
its prediction confidence was low. If, however, the predicted HLA-C allele frequently
occurs together with an HLA-B allele, we can use this relationship as a factor to boost
the confidence of a prediction of HLA-B.
While treating each gene independently in the prediction has shown successful in
prediction of common HLA alleles (the ones that are most frequent in the population),
prediction of rare HLA alleles has been more challenging. Their representation in the
population sample might not be sufficiently large for predictive models to generate a
confident prediction. A common practice in HLA prediction is then to only predict,
or make calls for the alleles that are predicted with high confidence, usually above a
pre-specified confidence threshold. Knowing that there are strong patterns of linkage
disequilibrium among HLA genes, and that certain alleles occur together more often
than what is expected by random chance, provides an additional source of information
which can be used in HLA prediction to improve prediction performance.
In Chapter 2 of this thesis we present a novel approach for prediction of HLA alleles
from SNP data that uses the structural information that exists in the HLA region. We
1 See Table 2.1 for definition of phase
6demonstrate that accounting for the highly correlated nature of HLA genes during the
prediction improves the prediction accuracy [53, 54]. The method accounts for high
correlation among the HLA alleles by using HLA population haplotype frequencies [20].
These frequencies inform us about the co-occurrence of alleles inferred from a wide
population and independent from the sample at hand. We use this information during
the prediction as a weighted factor with a gene-specific classifier.
In addition, we describe two different ways that HLA gene dependency information
can be incorporated into the prediction process and evaluate their impact on prediction
accuracy. We show that adding this information improves the prediction performance
on multiple real-world data sets and demonstrate that it is a valuable asset for HLA
gene prediction.
1.2.2 Quantifying uncertainty in HLA data
In hematopoietic stem cell transplantation the selection of donors for a patient in need of
a transplant is based primarily on HLA matching, and the lower the ambiguity of typing
the easier it is to determine the probability of allele level match during the donor search
[26]. In order to facilitate rapid identification of matched donors for HSCT several
methods have been proposed to infer unknown phase and allele assignment [19, 35].
They typically employ statistical methods and the unique properties of the HLA region,
such as its high linkage disequilibrium, in order to estimate haplotype frequencies and
predict the most likely haplotype assignment for an individual with an HLA typing
consisting of a set of ambiguous allele pairs. HLA typing with less ambiguity on average
gives fewer high-probability phased high resolution haplotypes. We aim to measure
per-gene ambiguity resulting from several HLA typing formats across four continental
populations using an information theory-based measure, Shannon’s entropy [71].
Some previous work has been done in measuring typing ambiguity – first a measure
developed by Helmberg et al. [22], and more recently, the first application of Shannon’s
entropy to this problem by Cano [8]. Helmberg proposed a characterization of HLA
typing kits using a frequency inferred typing (FIT) index. A FIT index describes the
probability of correct allele pair assignment for an ambiguous typing result, and is
calculated as the negative log of the probability of a wrong allele pair prediction. This
probability is equal to the sum of products of all allele pairs that share the same typing
7pattern as the selected pair. The limitation of the FIT index is that it does not take
into account the distribution of allele frequencies beyond the most likely assignment.
Both previous typing ambiguity studies used allele frequencies in their computations
and, as we will later show, fail to demonstrate the advantage of linkage disequilibrium
information contained in haplotype frequencies when it comes to reducing ambiguity
and improving predictions of patient-donor matching.
In Chapter 3 of this thesis we describe an information-theory based measure to
quantify ambiguity content in an HLA typing. We demonstrate that it can be objec-
tively used to compare methods of HLA typing to each other in terms of the infor-
mation they provide, in the context of each individual population. Our results show
that intermediate-resolution single-pass sequence-based typing (SBT) contains the least
ambiguity and, therefore, the most certainty in allele prediction across all populations.
In addition, we demonstrate the benefit of using haplotype frequencies in entropy cal-
culations versus allele frequencies. Neighboring HLA and non-HLA genes are highly
correlated and major efforts have been directed at describing linkage disequilibrium
(LD) across the region [11, 44, 80]. When certain alleles occur together generally due to
linkage disequilibrium between them, some ambiguity can be inferred away using this
linkage information, which is contained in haplotype frequencies. Our results show that
using population haplotype frequencies greatly reduces the ambiguity present in HLA
typing.
1.2.3 Prediction from uncertain HLA data
Allele and phase ambiguity found in most HLA data sets today presents a challenge
to current SNP-based methods for prediction of HLA alleles, since they require non-
ambiguous data. A way to obtain high-resolution HLA alleles from ambiguous data is
to use one of the existing methods for resolving ambiguity from the ambiguous HLA
data [36] and then use the generated high-resolution HLA alleles in learning the SNP-
based prediction method. However, depending on the levels of ambiguity in the HLA
data, the errors generated by these methods can be prohibitively high, up to 45% (this
error includes the error in both, allele and phase assignment, and should be interpreted
as the upper bound on the allele assignment error) [36]. These errors are then further
propagated when the incorrectly imputed HLA alleles are used to train the SNP-based
8prediction model.
In Chapter 4 we propose an approach to SNP-based prediction of HLA alleles that
handles allele ambiguity in the HLA genotypes, and thus uses ambiguous HLA data as
a learning source in the prediction [55]. Additionally, we evaluate how different levels
of ambiguity in HLA data impact the prediction performance. Finally, we demonstrate
that building the predictive model from ambiguous, rather than from statistically im-
puted high-resolution data, is a better approach to SNP-based prediction of HLA alleles.
1.3 Thesis Contributions to Computer Science
In this chapter we describe the contributions of this thesis to the field of computer
science. The methods we developed and described in this thesis directly contribute to
the areas of correlated multi-label multi-class prediction (Chapter 2) and learning from
uncertain data (Chapters 3 and 4). We begin by describing existing work in these areas
and conclude with limitation of existing methods to the problem at hand (the analysis
and prediction of HLA genes).
1.3.1 Correlated multi-label multi-class prediction
Prediction of HLA alleles can be treated as a correlated multi-label multi-class prediction
problem. Each HLA gene is a multi-class label. Labels are correlated because of the
strong linkage disequilibrium in this region.
Multi-label classification is concerned with learning from a set of instances that are
associated with more than one label, as opposed to traditional single-label classification
problems, where instances are associated with a single class label. Multi-label classifi-
cation problems are, nowadays, required by many applications, such as protein function
annotation, image labeling, and document categorization. For a comprehensive review
of techniques proposed in the area of multi-label classification and their applications
refer to [77, 74].
The multi-label prediction methods most relevant to prediction of HLA alleles are
those that account for the existence of dependence in the label set. The general agree-
ment in the literature is that it is important to take into account label dependencies
9during the classification process [3]. However, the problem of considering label de-
pendency during prediction has an exponential nature. A number of approaches are,
therefore, motivated by the computational demands of the correlated multi-label pre-
diction problem. We next describe the most recent developments and applications of
correlated multi-label prediction.
In protein function annotation, the goal is to predict functions of unannotated pro-
teins in the context of molecular networks, where a protein can be annotated with a
two or more functions which constitute the label set [28, 50, 76]. The algorithms in
this category takes into account domain knowledge by combining the data (e.g. gene
expression) and an existing structure related to the data, such as the Gene Ontology 2
or MIPS functional categories 3 . They then compute graph-topology related similar-
ity between labels, that is, proteins in the graph, and use this similarity to propagate
functional labels to unannotated proteins [28, 76]. The approach in [50] uses additional
information about the genes (gene expression data) and combines the similarity be-
tween genes with respect to their expression and similarity between genes with respect
to their relationship in the functional network. These approaches demonstrate that us-
ing the dependence between protein functions in the network can enable more accurate
functional annotation.
Several approaches are proposed that model multi-label prediction as a binary rel-
evance problem (BR) that incorporates label dependency by augmenting the feature
space with predictions made on individual labels [60, 18, 3]. In the BR approach a
multi-label classification approach is decomposed into multiple independent classifica-
tion problems for each label separately. Each instance in the training set is labeled as
positive if the given label is in the set of labels for that instance, and negative otherwise.
The final label set for each instance in the data set is generated by aggregating results
of classification over all individual classifiers. In [60] a chain of classifiers is formed to
predict binary association for a single label on the feature space augmented by all pre-
vious BR predictions in the chain. Since the order of labels in the chain can change the
prediction of the final label set, the authors address this issue by creating an ensemble
of randomly ordered chains of classifiers and using predictions of each chain classifier
2 http://www.geneontology.org/
3 http://mips.helmholtz-muenchen.de/proj/ppi/
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as votes. In [18], the authors create a two-stage classifier where they use SVM, as the
first step, on the original feature set which returns predicted scores for each sample and
each label independently. In the second step, the original feature step is augmented
with these scores, which reflect the dependence between labels, and SVM is applied
again. The method in [3] has a similar approach, but is not restricted to one underlying
classification method (SVM in [18]), and also addresses possible over-fitting.
Several approaches predict correlated labels by augmenting the original label set
with its power set. The most recent and promising approach in this category is de-
scribed in [78]. They avoid the computational complexity of power set approaches for
datasets with large numbers of labels by building an ensemble framework where each
classifier is a single-label classifier for the prediction of a power set of a random small
subset of labels. Lastly, generative approaches are proposed to learn joint distribu-
tions of features and labels. The most recent such approach is described in [15] where
two graphical models are built to learn parameters associated with feature-label-label
triplets, therefore, capturing the impact that an individual feature has on co-occurrence
with a pair of labels. This approach proved efficient, but is restricted to pairs of labels
only.
Challenges to Using Multi-label Prediction for HLA Prediction
There are several challenges, dictated by the nature of the data, to applying existing
multi-label prediction methods to the HLA inference problem. As described earlier, most
of the existing methods were developed in the areas of protein function annotation, text
categorization and image annotation, where the existence of binary labels is assumed,
e.g. a protein either has a specific function or not, a document either belongs to ’Sport’
category or not, and so on. In addition, a data point can be assigned an arbitrary
number of labels, e.g. an image can be classified as ’Sky’ or it can be classified as ’Sky’,
’Sea’, and ’Summer’, that is, there is no strict constraint on the number of labels a data
point can be assigned. We next explain these and other issues in more detail.
• Sparse label space
HLA prediction is a problem of predicting a small number of HLA labels (genes)
from SNP data where each label has a large number of values (HLA alleles). In
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a simple example, we are interested in predicting HLA-A, -B, and -DRB1 genes
for a particular sample in which the number of known alleles for each gene is
NA = 450, NB = 300, NDRB1 = 200, respectively. We cannot directly apply
any of the existing methods that assume binary labels to this problem, as the
labels are categorical. We can, however, convert categorical labels into binary,
by creating NA, NB, NDRB1 binary labels instead of the three categorical ones.
Each data point is assigned ’1’ for exactly three attributes corresponding to its
three alleles, and ’0’ otherwise. Note that each data point is assigned exactly N
labels, where N is the number of genes. This makes the label space extremely
sparse, since HLA prediction is concerned with predicting several HLA genes, that
is, predicting several binary labels out of hundreds or thousands of possibilities.
• Non-arbitrary number of labels
Even though the conversion of categorical into binary labels takes care of the
binary label assumption, we still run into problems with existing multi-label pre-
diction algorithms due to their lack of constraint on the number of predicted
labels. A data point can be assigned 1 or any arbitrary number of binary labels
depending on the problem at hand and the parameter setup of the algorithm. For
example, an image can be annotated with ’Sky’, ’Sea’, ’Summer’, and ’Ocean’
labels, but any subset of these labels would be a correct solution as well. For the
prediction of N HLA alleles in a binary label set scenario, we are concerned with
predicting exactly N binary labels for each subject. An additional constraint is
that these N binary labels cannot be selected randomly from the label set, but
each of them has to belong to a disjoint set of alleles describing each gene. In
the example described above, the number of binary labels is NA +NB +NDRB1,
and we are concerned with predicting exactly three labels so that each one comes
exclusively from NA, NB and NDRB1 alleles, respectively. Such a constraint is
not required in applications like protein function annotation, text categorization
and image annotation, and therefore not enforced in algorithms designed for these
applications.
• Lack of additional structure
In some multi-label classification problems, e.g. protein function annotation, the
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classification is commonly assisted by an additional structure describing relation-
ships among labels. For example, for two genes, one with known and one with
unknown function, that have similar expression profiles, a protein interaction net-
work is used to propagate the function along the edges and annotate the unknown
gene. Taking such structures into account in multi-label prediction is important,
because it can lead to improved predictive power and computational efficiency.
Computing such additional structure on the binarized HLA label set would be
very challenging due to its sparsity and high-dimensionality as mentioned above.
In addition, since the relationships between alleles of the same gene are not useful,
we only need to compute the relationships between labels belonging to different
HLA genes, but not among them. This would result in an overall sparse structure
with possibly many disconnected nodes (HLA alleles on one gene that are not
correlated with any other alleles on other genes). Such a disconnected structure
might not be as great an asset to the HLA inference problem as the traditional
protein functional network is to the functional annotation of genes.
• Need for SNP phasing
Lastly, humans are diploid organism, that is, we have two copies of each chromo-
some, one from the mother and one from the father. This has a direct implication
in HLA prediction in that we need to predict alleles of both copies of HLA genes,
which, due to the high polymorphism of this region, are more often different than
not. SNP genotype data, which we start from, is reported in unphased form, that
is, each person has one genotype (for definitions of phase and genotype, see Table
2.1). In order to impute two alleles for each HLA gene, we need the assistance
of SNP data arranged on each chromosome separately, that is the SNP haplotype
data. This is why all existing algorithms in HLA prediction either use phased
SNP data as a starting point, or a phasing algorithm to infer SNP haplotypes
before or during HLA prediction. The performance of SNP phasing will impact
the follow-up analysis and, therefore, special attention needs to be taken at this
step.
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As seen above, HLA prediction cannot be safely treated as a traditional multi-label
prediction problem due to its particular nature and many prediction constraints result-
ing from it. Solving HLA prediction with the help of multi-label prediction requires
modification of existing algorithms or the design of new ones with HLA specific charac-
teristics in mind. The method for correlated multi-label prediction of HLA genes that
we describe in Chapter 2 directly address all of the above challenges. It can be easily
applied to other problems of similar nature, such as SNP imputation or prediction of
other genomic regions, or adapted to solve problems of simpler nature, such as any
multi-label multi-class prediction that does not require genomic phasing.
1.3.2 Analysis and learning from uncertain data
Traditional data mining methods assume the data are complete and exact. However, in
many applications data points are uncertain due to a number of factors including noise,
measurement errors, aging data collection methods, etc. For example, in demographic
data sets, the information about household income is often aggregated rather than
known for every individual [1]. Uncertain data present a challenge to data mining
techniques since most of them assume certainty and are not equipped to deal with
inexact or noisy data.
Despite numerous classification algorithms for exact data, the work in the area of
prediction from uncertain data remains limited. A modified support vector machine
algorithm was proposed in [82] that handles input uncertainty. The modified algorithm
adjusts the margin based on the uncertainty of data points which lie on the boundary.
The authors showed that by modeling input uncertainty, they could obtain more accu-
rate predictions when compared to the standard SVM classifier. A modified naive Bayes
classification of uncertain data has been developed that extends the class conditional
probability estimation in the Bayes model to handle probability distribution functions
defined over uncertain data points [61]. The method was tested on several data sets
that contain uncertainty and demonstrated that the proposed distribution-based method
outperforms naive Bayes on a specific data set obtained by replacing each probability
density function with its expected value. A decision tree based classification method has
been developed for uncertain data by modifying partitioning measures, such as entropy
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and information gain, to accommodate probabilistic nature of the attributes [58]. Sim-
ilarly, a rule-based classification algorithm for uncertain data has been described that
uses probabilistic information gain for generating rules [59]. For a comprehensive review
of data mining techniques for storage and analysis of uncertain data refer to [2, 45].
We next describe the limitations of existing approaches to our application.
• All existing methods for learning from uncertain data are developed for one-label
problems, and do not accommodate the multi-label applications, such as ours.
Even if these methods were to be applied on our data one-label at a time, therefore
reducing the problem to a one-label problem, there are still other limitations to
using traditional classification approaches in our application, described in detail
in the previous Section 1.3.1.
• Most of described existing methods assume numerically uncertain data points, or
data points that can take on any value from a defined distribution or from a certain
range of values [82, 61, 1]. However, uncertainty can also occur in categorical data.
For example, a tumor is often difficult to accurately classify due to limitations in
lab experiment precision. Therefore, doctors may often classify a tumor as benign
or malignant with a certain probability [58]. In this thesis, we deal with categorical
uncertainty in the form of uncertain HLA assignments.
In Chapters 3 and 4 we describe novel algorithms for the analysis and prediction
of uncertain HLA data. Molecular typing of HLA data is often returned by the typing
laboratories as an ambiguous set of possible alleles, all equally likely. In Chapter 3 we
propose a novel entropy-based algorithm for quantifying the uncertainty in the data.
In addition, we demonstrate that the correlation that exists among uncertain data,
can eliminate some of the originally reported uncertainty. In Chapter 4 we propose
a novel EM-based algorithm for prediction of uncertain categorical labels. The EM
algorithm iterates through all samples and all possible resolutions of uncertain data
points, to estimate the distribution of all possible outcomes. The framework can be
easily adopted for prediction of uncertain categorical data in other applications.
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1.4 Thesis Overview
The organization of this thesis is summarized in Table 1.1. We begin in Chapter 2 by
describing correlated SNP-based prediction of HLA alleles. In Chapter 3, we describe a
method to quantify ambiguity in HLA data, and demonstrate on simulated data that a
method is well suited to compare common HLA typing methods. Chapter 4 describes
a method that utilizes available ambiguous HLA data sets for SNP-based prediction
of HLA alleles by incorporating the ambiguity into the training process. Finally, we
conclude the thesis in Chapter 5 with discussion and proposed future work.
Table 1.1: Thesis Organization: Prediction and Analysis of HLA Data
Exact data Uncertain data
Prediction Prediction of HLA data from
SNPs (Ch. 2)
Prediction of HLA data from
SNPs and ambiguous HLA
(Ch. 4)
Uncertainty
evaluation
Measuring ambiguity in HLA data using haplotype frequencies
(Ch. 3)
Chapter 2
Prediction of HLA Genes from
SNP Data
2.1 Introduction
Obtaining HLA data for large disease-association studies may be of great value for learn-
ing about biological mechanisms behind many diseases. However, due to the high cost of
HLA typing, obtaining that data for large studies may be impractical. In this chapter we
present an approach for prediction of HLA genes from existing Single Nucleotide Poly-
morphisms (SNP) data with the goal of enriching available large genome-wide studies
with this valuable new information. For terminology used in this and upcoming chap-
ters, see Table 2.1.
2.2 Existing Work in HLA Imputation
Several methods have been developed and used to infer HLA alleles from SNP data
[11, 32, 70, 43, 34]. We next divide them into several categories and briefly describe
them.
Method that uses tag SNPs to infer HLA alleles
Initial attempts in HLA inference from SNP data proposed the use of tag SNPs to
infer common HLA alleles [11]. This study observed that there is a strong linkage
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Term Definition Example
Diploid Having two copies of DNA or pairs
of homologous chromosomes. Hu-
mans are diploid organisms.
Phase A physical ordering of markers
(SNPs, alleles) along a chromosome.
Haplotype An arrangement of markers (SNPs,
alleles) on a chromosome. When a
physical arrangement of a set of al-
leles is known, we also say that the
data is phased (or that the phase
is known).
A T G C (sometimes writ-
ten as A ∼ T ∼ G ∼ C)
Genotype
(un-phased
genotype)
A set of un-phased markers for
diploid organisms (no information
on physical arrangement of alleles
on chromosomes).
A/T T/T G/A C/T
Haplotype pair
(phased geno-
type)
A physical ordering of markers
(SNPs, alleles) along the two chro-
mosomes in diploid organisms.
A T G C, T T A T (some-
times written as A ∼ T ∼
G ∼ C, T ∼ T ∼ A ∼ T )
kb = (kbp) kilo base pairs = 1, 000bp. Base
pair(s), bp, is a unit commonly used
to describe the length of a D/RNA
molecule.
50kbp
Table 2.1: Terminology used in the thesis.
disequilibrium [13] between genetic markers and some HLA alleles and listed several such
associations. Although the study demonstrated efficient prediction of some common
HLA alleles using one or two SNP markers, this approach does not provide a solution
to accurate HLA inference. HLA genes are highly polymorphic with many rare alleles,
which are hard to predict using a small number of tag SNPs. Additionally, a large
number of HLA alleles would require a large number of tag SNPs to be identified.
Finally, the identification of tags in a small sample could cause over-fitting, since the
selected SNPs might be sample-specific and not generalize well to future data.
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Methods that use phased SNP haplotypes to infer HLA alleles
Another set of approaches aim to improve the performance of tag SNPs for HLA predic-
tion by utilizing the joint distribution of SNPs in the MHC genomic region as reflected
in SNP haplotypes [32, 70, 43]. In genetics, a haplotype, also known as a phased geno-
type, is a physical ordering of markers (SNPs, alleles) along a chromosome. Note that
this arrangement needs to be inferred using statistical methods or pedigree information,
since sequencing of the genome is performed simultaneously on both chromosomes, and
an individual’s genotype, and therefore, does not uniquely define their haplotype.
Leslie et al. [32] proposed HLA inference from SNP haplotypes. They assume prior
availability of phased SNP and HLA data, either previously known or estimated. Their
method is based on the assumption that a chromosome carrying an HLA allele is an
imperfect mosaic of other chromosomes with the same allele. Given training data of
SNP haplotypes and the corresponding phased HLA alleles, a hidden Markov model is
used to compute the probability that a chromosome with a given SNP haplotype carries
a particular HLA allele. This method requires a fine genetic map of input SNP data.
Similarly, approaches in [70, 43] rely on family trios to infer genotype phase more
precisely. This information, however, is rarely available in large SNP data sets. Ap-
proaches in this category either start from SNP haplotype data or infer the phase from
SNP genotypes and then impute HLA alleles. SNP haplotypes are not always avail-
able and need to be inferred using one of many genotype phasing methods [6]. The
performance of phasing methods, therefore, impacts the follow-up analysis and HLA
imputation.
Methods that use SNP genotypes to infer HLA alleles
In this set of approaches, HLA alleles are inferred from a set of selected SNPs in the
MHC region [34]. Instead of using SNP haplotypes, the method described in [34] builds
a predictive model for each HLA gene using unphased SNP data from a set of 630 in-
dividuals as the training set and tested it on a set of 630 unrelated individuals. This
method uses a maximum likelihood framework based on all the HLA and SNP genotypes
in the sample, identifies the most informative SNPs and computes predictive probabili-
ties for all possible HLA allele pairs, given the SNP genotype data. The pair with the
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maximum probability is predicted to be the HLA type for that sample if the probability
exceeds a pre-specified confidence threshold (ct); otherwise, no prediction is made. Typ-
ically ct is set to zero, meaning all samples are predicted, that is, the call rate is 100%.
When ct is increased, the accuracy generally increases. However, the call rate drops,
in some cases to around 35%. Empirical evaluation of known issues in HLA inference
is described in [84] and demonstrated with the methods in [34] on several datasets of
different ancestries and different typing methodologies. Lastly, the application of the
proposed inference method on several other polymorphic genes is shown in [83].
2.3 Limitations of existing work
All existing approaches make predictions for HLA alleles for each gene independently.
They consider each HLA gene as an independent label in a multi-label prediction sce-
nario, and build predictive models with respect to each label separately. Since many
HLA alleles are known to be in linkage disequilibrium [13], we can take advantage of this
label dependency to assist the HLA inference and potentially improve its accuracy. This
is especially relevant since many of the existing algorithms use a confidence threshold
(ct) to decide whether they want to make a prediction or not. If ct is set to zero, all
samples are predicted and the accuracy of prediction is typically lower. If ct is set to
a number greater than zero, the accuracy of prediction increases, but not all samples
are assigned HLA alleles. Using the relationship between HLA alleles can boost the
confidence of the prediction and increase the call rate on the entire data sample. For
example, we might predict an individual’s HLA-A allele with high confidence, but not
the HLA-B allele since its prediction confidence was low. If, however, the predicted
HLA-A allele frequently occurs together with an HLA-B allele, we can use this relation-
ship as a factor to boost the confidence of a prediction of HLA-B. The flowchart of the
HLA imputation using HLA dependence in prediction is shown in Figure 2.1.
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Figure 2.1: Flowchart of correlated HLA imputation from SNP data. The dashed line
indicates that label dependencies can be inferred from the training sample or from a
larger population, as is the case in our proposed work.
2.4 Proposed Approach
Prediction of HLA alleles from SNP data has been more or less successfully applied.
Existing methods treat each gene independently and train a predictive model on each
gene to predict an allele on that gene. While this approach has been successful in
prediction of common HLA alleles (the ones that are most frequent in the population),
prediction of rare HLA alleles has been more challenging. Their representation in the
population sample might not be sufficiently large for predictive models to generate a
confident prediction. A common practice in HLA imputation is then to only predict,
or make calls for the alleles that are predicted with high confidence, usually above a
pre-specified confidence threshold. Knowing that there are strong patterns of linkage
disequilibrium among HLA genes, and that certain alleles occur together more often
than what is expected by random chance, provides an additional source of information
which can be used in HLA imputation to improve prediction performance.
We use the population haplotype frequency to inform us about the co-occurrence
of alleles inferred from a wide population and independent from the sample at hand.
We use this information during the prediction as a weighted factor with a gene-specific
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classifier.
2.4.1 Top k predictions
We first select a set of possible HLA allele predictions by using SNP genotype data.
We do this by running genotype data through an EM classifier and selecting the top
k predictions for each gene independently. To obtain the best k guesses we use SNPs
around each HLA gene separately, that is, to classify HLA-A alleles, we use SNPs around
this region only, and so on. This step is shown in Figure 2.2. We discuss the details of
this step later in this section.
Figure 2.2: To obtain top K predictions for each HLA gene, we compute the probability
of the test sample having every possible pair of alleles for a given gene and keep the K
predictions with the highest probabilities.
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For the prediction of each gene, we select a subset of SNPs within and around that
gene. For this study we use a region of ±50kb around each gene (for definition of kb
refer to Table 2.1). We then train a classifier using these SNPs only to select the top
k predictions for each gene. Note that genotype data compresses the sequence of two
chromosomes into one vector, so that each of the k predictions will be a pair of HLA
alleles, one for each chromosome, as shown in Figure 2.2. For example, the top k = 3
predictions for gene HLA-A in Figure 2.2 are
A ∗ 01 : 01, A ∗ 01 : 01
A ∗ 01 : 01, A ∗ 01 : 06
A ∗ 66 : 08, A ∗ 01 : 06
In the next step we enforce additional structure in the allele (label) space to refine
the search and predict HLA alleles.
2.4.2 Population HLA haplotype frequencies
HLA genes are correlated because of the strong linkage disequilibrium in this region.
We can utilize the structure that exists between the genes as an additional source of
information in order to improve the prediction.
Given a set of likely predictions of a new sample with unknown HLA alleles found
in the previous step, we use population haplotype frequencies [37] to narrow down the
selection of HLA alleles and make final predictions. The haplotype frequencies are
estimated at the level of the entire US population and inform us of how likely sets of
alleles are to co-occur in each separate population [37]. We utilize the structure that
exists between the labels as an additional source of information in order to improve the
prediction.
Given a set of HLA haplotypes hj = (A ∼ C ∼ B ∼ DRB1 ∼ DQB1) and their
population specific frequencies fj , the frequency of any subset of genes (in this example
genes C and B) can be calculated as
f(CJ ∼ BK) =
∑
j
fj(A ∼ CJ ∼ BK ∼ DRB1 ∼ DQB1) (2.4.1)
Now, given any number of HLA genes, a table similar to Table 2.2 can be constructed
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to describe the dependency between those genes. This will become relevant when we
use local haplotype information to inform the final predictions. Note that we here use
a common notation of haplotypes which is a sequence of genes separated by the ∼ sign.
Table 2.2: HLA haplotype frequency table containing haplotypes and the frequencies
with which they occur in a given population.
A C B DRB1 DQB1 Frequency
01:02 07:01 07:02 07:01 02:01 6.79× 10−7
01:02 07:01 07:02 15:01 06:02 1.032× 10−5
01:02 07:01 08:01 11:02 03:01 1.031× 10−5
... ... ... ... ... ...
2.4.3 Combining top k predictions and haplotype frequencies
Once we obtained the top predictions of allele pairs and constructed the HLA haplotype
frequency table, we combine the two to make a prediction. This step is shown in Figure
2.3.
Given a set of selected allele pairs for each gene, we generate all possible pairs of
HLA haplotypes. Let’s call this set H. For example, given the top k = 3 predictions for
genes HLA-A, -B, and -DRB1 shown in Figure 2.3, some of the possible HLA haplotype
pairs combining those predictions are the following:
(h1, h2) =

A ∗ 01 : 01 ∼ B ∗ 07 : 01 ∼ DRB1 ∗ 01 : 01, A ∗ 01 : 01 ∼ B ∗ 08 : 02 ∼ DRB1 ∗ 03 : 01
A ∗ 01 : 01 ∼ B ∗ 08 : 01 ∼ DRB1 ∗ 01 : 01, A ∗ 01 : 01 ∼ B ∗ 13 : 02 ∼ DRB1 ∗ 03 : 01
A ∗ 01 : 01 ∼ B ∗ 07 : 01 ∼ DRB1 ∗ 01 : 01, A ∗ 01 : 01 ∼ B ∗ 15 : 01 ∼ DRB1 ∗ 03 : 01
A ∗ 01 : 01 ∼ B ∗ 07 : 01 ∼ DRB1 ∗ 01 : 01, A ∗ 01 : 06 ∼ B ∗ 08 : 02 ∼ DRB1 ∗ 03 : 01
...
A ∗ 66 : 08 ∼ B ∗ 07 : 01 ∼ DRB1 ∗ 01 : 01, A ∗ 01 : 06 ∼ B ∗ 15 : 01 ∼ DRB1 ∗ 10 : 01
Each of the k predictions comes with a prediction score, let us denote it as SA. This
score could be prediction confidence, similarity with the test sample, or some other
statistic returned by the classifier. These scores are assigned to individual alleles in
the following manner: if prediction score of (A1, A2) is 0.4, both alleles A1 and A2 are
individually assigned 0.4.
Given a haplotype frequency table constructed from the population haplotype fre-
quencies, we retrieve the frequency of each HLA haplotype from H and assign a score
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Figure 2.3: To incorporate haplotype structure into the prediction, we combine top
prediction into all possible pairs of haplotypes and use haplotype population frequencies
to refine the top prediction.
to each pair of haplotypes by multiplying their respective frequencies. In the above
example, if haplotype h1 = A∗01 : 01 ∼ B ∗07 : 01 ∼ DRB1∗01 : 01 has a frequency f1
and haplotype h2 = A ∗ 01 : 01 ∼ B ∗ 08 : 02 ∼ DRB1 ∗ 03 : 01 has a frequency f2, then
the frequency of the haplotype pair is equal to f1 ∗ f2. This frequency is labeled SH .
Here we assume that the two haplotypes occur independently in an individual. This
assumption is known as a Hardy-Weinberg equilibrium or the assumption of random
mating in a population.
To select the most likely pair of haplotypes for a test sample with unknown HLA
alleles, we combine SA and SH into a final haplotype score S and make a prediction
by selecting the highest ranking pair of haplotypes. For now, we denote the prediction
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score as a function of SA and SH as follows
S = f(SA, SH) (2.4.2)
The method is shown in Algorithm 1.
Algorithm 1 HLA Imputation
for each new sample s do
Construct gene-specific classifiers
Find k top predictions for s for each gene
Assign prediction likelihoods as allele scores of top k allele pairs
Using top predictions, generate all possible pairs of HLA haplotypes
Retrieve haplotype frequency for candidate haplotypes
Compute a score that combines allele and haplotype scores
Determine a pair of haplotypes such that the overall score is maximized
end for
2.4.4 Contributions of the proposed approach
Here we list the contributions of our approach.
1. Instead of treating HLA genes independently and predicting alleles separately for
each gene, we propose an approach that takes advantage of high linkage disequi-
librium in the region. Additional information brought in by haplotype frequencies
describing allele co-occurrence on the population level improves the prediction.
Additionally, this structure brings into the prediction information about the gen-
eral population that cannot be deduced from the sample at hand. It makes our
algorithm more generalizable to samples of different sizes or ethnic backgrounds.
2. Our approach makes predictions for all test samples regardless of the confidence
thresholds used for the base classifier.
3. An additional advantage of our approach is the prediction of all HLA haplotypes,
rather than separate alleles. Our algorithm can be easily extended to return a
ranked list of HLA haplotypes that a new sample is likely to have. This is valuable
in the context of stem cell transplantation where donor search is performed based
on the highest ranking imputed haplotype pairs.
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2.5 Implementation of the approach
As described in the previous section, the first step in the prediction of HLA alleles of a
new sample is predicting the top k allele pairs by running a classifier on SNP genotype
data. We implemented this step by using an Expectation-Maximization (EM) classifier
which has been extensively used in estimation of haplotype frequencies [37, 29]. We use
EM to model the joint distribution of SNP and HLA alleles by estimating the frequency
of the their joint haplotypes, and then use Bayes’ theorem to compute the probability
of a pair of HLA alleles given a new sample with SNP genotype data. We describe this
methodology in more detail in the following section.
2.5.1 Selecting the top k allele pairs
Building the model using training data
The EM algorithm has been described in detail in [29], and we summarize it here briefly.
Given HLA and SNP genotypes for all samples in training data set, EM estimates the
frequencies of all haplotypes that could be obtained from observed genotypes, using the
following two steps:
• E-step (Expectation) - Current haplotype frequencies are used to calculate for
each subject conditional probabilities of each possible pair of haplotypes. These
are then used to update current frequencies of each possible pair of haplotypes.
• M-step (Maximization) - The updated haplotype pair frequencies from previous
step are used to update haplotype frequencies. In the initial step, haplotype
frequencies are set to 1/nh where nh is the number of unique haplotypes in the
data set.
These steps are also shown in Figure 2.4. In the first step EM uses the entire training
data set and expands the training genotypes into all possible pairs of haplotypes (essen-
tially phasing the data or assigning the observed genotypes to the two chromosomes).
An example of this expansion for one sample is shown in Figure 2.5. EM expands the
entire training data set and collects all unique (SNP, HLA) haplotypes from the set of
expanded haplotype pairs. It assigns initial frequencies of all haplotypes to be equal
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(1/nh, where nh is the number of unique haplotypes). EM then iterates through the
E-step and M-step, using the equations shown in the Figure 2.4, until the estimated hap-
lotype frequencies do not change beyond a certain threshold or a pre-specified number
of iterations is exceeded.
Figure 2.4: Expectation-Maximization (EM) algorithm for estimation of haplotype fre-
quencies.
The outcome is a set of joint (SNP,HLA) haplotypes h = (ga, sa1 , sa2 , ..., sam) that
could be obtained from the observed genotype data in the training sample and their
estimated frequencies f(ga, sa1 , sa2 , ..., sam) where ga denotes a gene allele, sa denotes a
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SNP allele and m is the number of SNPs.
Making a prediction for a test sample
Let gi = (gi1, gi2) denote an HLA genotype of each subject i and si = (sij ,∀j ∈ [1,m])
represent a SNP genotype and let ga and sa denote a gene and a SNP allele, respectively.
Given estimated haplotype frequencies f(ga, sa1 , sa2 , ..., sam), and a new sample with a
SNP genotype s′ = (s′j ,∀j ∈ [1,m]), the probability that this sample has any two HLA
alleles g = (g1, g2) can be calculated as follows
P (g|s′) ∝ P (g, s′) (2.5.1)
where P (g, s′) = P (g1, g2, s′) is a joint probability of HLA and SNP genotypes,
and can be obtained by summing the frequencies over the set H of all (HLA,SNP )
haplotype pairs that could be expanded from that genotype, as follows:
P (g, s′) = P (g1, g2, s1, s2, ..., sm) =
∑
H
f(g1, sa11 , sa21 , ..., sam1)∗f(g2, sa12 , sa22 , ..., sam2).
(2.5.2)
An example of expanding a new SNP genotype s′ and an allele pair g = (A ∗ 01 :
01, A∗02 : 50) into all possible pairs of haplotypes and computing their joint probability
is shown in Figure 2.5.
The predicted HLA allele pair for a new SNP genotype s′ is that for which the
probability P (g|s′) is maximal:
(g′1, g
′
2) = arg max
(g1,g2)
P ((g1, g2)|s′). (2.5.3)
The prediction score is assigned to each of the two selected alleles, in order to obtain
an allele score. We use the allele scores later along with population haplotype frequencies
to make the final predictions.
Sg′1 = Sg′2 = P ((g1, g2)|s′) (2.5.4)
Our confidence in this prediction is dictated by the maximal probability. In order
to keep strong predictions and reduce the complexity of the problem later on, we do the
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Figure 2.5: An example of expansion of genotypes into pairs of haplotypes.
following:
• If highest prediction probability exceeds pre-set threshold ct, we keep top one pair
of alleles.
• If highest prediction probability does not exceed ct, we keep top k allele pairs.
We do this in an HLA gene-specific manner, that is, using SNPs around each HLA
gene separately, to obtain top predictions for each sample in the testing data and for
all loci L ∈ {HLA−A,−C,−B,−DRB1,−DQB1}.
We then move on to incorporating HLA haplotype frequencies into our final predic-
tion.
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2.5.2 Prediction score
Once we have selected allele pairs for each gene, we list all possible haplotype pairs
h = (h1, h2) resulting from these alleles. Each of these haplotype pairs is assigned an
allele score SA and an haplotype score SH as follows:
SA =
1
NL
∑
g
Sg (2.5.5)
SH = f(h1) ∗ f(h2) (2.5.6)
where the summation is over all alleles g in haplotype h, and f(h) is the haplotype
frequency of h. Each haplotype pair h is then assigned a weighted score
S = (1− δ)SA + δ ∗ SH (2.5.7)
where δ ∈ {0, 1}.
The predicted pair of haplotypes for a new sample is the one with the highest score
(Figure 2.3). For small δ, predictions are based more on allele score SA and less on
haplotype score SH , that is the population haplotype frequencies, and vice versa.
2.5.3 Results
Data sets: We used HLA and SNP data from the International HapMap project4. This
data set contains 90 individuals of African ancestry (YRI), 180 individuals of European
ancestry (CEU), 89 individuals of Asian ancestry (ASI) - 44 Japanese (JPT) and 45
Chinese (HCB). These individuals are typed at 6,300 SNPs in the MHC region and 6
HLA loci (HLA-A, -C, -B, -DRB1, -DQA1, -DQB1).
The haplotype frequencies we used in this study were published in [37]. They contain
7,987 haplotypes and their relative frequencies in African, European, Asian and Hispanic
populations.
Experimental setup: For each data set, we randomly selected 80% of samples to
use as a training set and 20% of samples to use as a test set. We then used the proposed
approach to predict the HLA alleles for all test samples and computed the accuracy of
4 http://hapmap.ncbi.nlm.nih.gov/
31
the prediction (for each gene separately) by comparing the obtained alleles on the two
predicted haplotypes with the true alleles for that sample. More precisely, we computed
accuracy as follows:
accuracyL =
∑ |PL ∩ TL|
2 ∗NT (2.5.8)
where the summation is over all test samples. PL and TL are predicted and true
alleles at that gene, respectively, and NT is the number of test samples. We additionally
computed the overall accuracy of prediction across all HLA loci and across all test
subjects. This accuracy is equal to the percentage of correctly predicted alleles across
all HLA loci:
accuracyoverall =
1
NL
∑
L
accuracyL (2.5.9)
where P and T are predicted and true alleles for all HLA loci.
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Figure 2.6: Prediction accuracy versus parameter delta. This figure illustrates the need
to use HLA allele dependence to assist the prediction of HLA alleles. Figures 2.6(a),
2.6(b), 2.6(c) show gene-specific accuracy and correspond to the three study populations:
CEU (European), YRI (African), and ASI (Asian). Different population frequencies are
used for each population group. The color legend for 2.6(a), 2.6(b), 2.6(c) is shown in
2.6(a).
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Figure 2.7: Overall accuracy across all HLA genes for each population.
We varied the threshold δ to demonstrate the need for using haplotype frequency
in allele prediction. Figure 2.6 shows gene-specific prediction accuracy (Figures 2.6(a),
2.6(b), 2.6(c)) and the overall accuracy (Figure 2.5.3) for each study population using
the proposed method. We used k = 3 top predictions in the first step, and varied δ.
The figures demonstrate that as we increase δ, the accuracy generally increases. This
means that we positively assist the prediction if we add the haplotype frequencies. For
δ = 0 the prediction is based solely on allele score which is computed from genotype
data independently of haplotypes and allelic relationships.
It is evident from Figure 2.6 that improvement in accuracy varies for different loci
and population groups. Gene HLA-B is the most polymorphic gene in the HLA system
and therefore it’s prediction tends to be the most challenging. We see that the accuracy
for HLA-B is increasing with δ in the ASI population (Figure 2.6(c)), but not in the
CEU (Figure 2.6(a)). In the next section we investigate how linkage or correlation
between subsets of genes (local linkage) rather than all genes (global linkage) impact
the prediction performance.
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2.6 Evaluation of Label Dependency for the Prediction of
HLA Genes
In the previous sections we demonstrated that accounting for the highly correlated na-
ture of HLA genes during the prediction improves the prediction accuracy [53]. In this
section we propose an improvement of the original method that more systematically
deals with the selection of top predictions in the first step of the algorithm. Addi-
tionally, we propose two different ways that HLA gene dependency information can
be incorporated into the prediction process and evaluate their impact on prediction
accuracy. Next two sections describe these novelties.
2.6.1 Selecting top allele predictions
The improvement to the original method is introduced in the first step of the method
that deals with selection of top predictions. In our previous work, we used a fixed k
to select top k prediction. We now propose a more systematic approach that uses a
cumulative likelihood of predictions to select top most likely ones.
As the first step in the algorithm, we select a set of possible HLA allele predictions
by using SNP genotype data. We do this by running genotype data through a classifier
and selecting the top most likely predictions. This was done for each gene separately
to obtain top predictions for each sample in the testing data and for all genes (HLA−
A,−C,−B,−DRB1,−DQB1), as shown in Figure 2.8. Note that the predictions for
each gene will now have a different set of prediction candidates.
In order to keep the top predictions we do the following:
• Sort the predictions in descending order of their prediction likelihood.
• Move down the sorted list until the cumulative prediction likelihood exceeds a
prespecified threshold t.
• Keep the visited predictions including the one visited last.
For example, given the output of the classifier for gene HLA-A shown in Table 2.3, and a
thresholds t = 0.95, we keep the first three predictions, since their cumulative likelihood
equals 0.96 and as such exceeds the threshold t.
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Figure 2.8: To obtain top predictions for each HLA gene, we compute the probability
of the test sample carrying any pair of alleles for a given gene and keep the ones with
the highest probabilities.
2.6.2 Combining allele and haplotype information into a prediction
Global haplotype structure
Once we obtained the top predictions of allele pairs and constructed the HLA haplotype
frequency table, we combine the two to make a prediction. In the global haplotype
structure approach, we combine predictions of all HLA genes into haplotypes and use
their corresponding frequencies in the same manner as in Section 2.4.3. We briefly
summarize it here.
Each of the top predicted HLA allele pairs obtained by EM comes with a predic-
tion score, denoted as Sg. These scores are assigned to individual alleles on resulting
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Table 2.3: An example output of the base (EM) classifier for HLA-A gene.
prediction likelihood
A*01:01, A*01:16 0.8
A*01:02, A*02:01 0.1
A*01:02, A*02:01 0.06
A*01:02, A*24:02 0.04
candidate haplotypes. Each haplotype pair h = (h1, h2) from a set of haplotypes H
generated from top predictions is assigned an allele score SA and haplotype score SH as
follows:
SA =
1
N
∑
g
Sg (2.6.1)
SH = f(h1) ∗ f(h2) (2.6.2)
where N is the number of genes in the haplotype and the summation is over all alleles
g in haplotypes, and f(h) is haplotype frequency of h. To select the most likely pair of
haplotypes for a test sample with unknown HLA alleles, we combine SA and SH into a
weighted score S as follows:
S = f(SA, SH) = (1− δ) ∗ SA + δ ∗ SH (2.6.3)
where δ ∈ [0, 1].
The predicted pair of haplotypes for a new sample is the one with the highest score S.
For small δ, predictions are based more heavily on allele score SA and less on haplotype
score SH , and vice versa. We term this approach global haplotype structure to
emphasize that the prediction is based on the global all-gene haplotypes, that is, using
the dependency information over the entire set of labels (genes).
Local haplotype structure
Genes that are closer to each other on the chromosome exhibit stronger linkage disequi-
librium than genes that are further apart. In the context of HLA, genes C and B are
more strongly linked with each other than they are with gene A. The same is true for
genes DRB1 and DQB1. This is because of their proximity on the chromosome as can
be seen in Figure 1.1.
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Here we investigate how the local linkage, or the local haplotype structure, as
we refer to it here, between genes C and B and genes DRB1 and DQB1 affects the
prediction of C and B, and DRB1 and DQB1 genes, respectively. For the simplicity
of notation, we refer to genes DRB1 and DQB1 as DR and DQ in the equations to
follow. We use local haplotypes (C ∼ B and DRB1 ∼ DQB1) instead of global
(A ∼ C ∼ B ∼ DRB1 ∼ DQB1) haplotypes, as the second step in prediction. To
obtain local haplotype frequencies, we use Equation 2.4.1.
The selection of top predictions at each HLA gene along with their alleles score Sg
is the same as in the previous section. Once we have selected allele pairs for each gene,
we list all possible local HLA haplotype pairs
h(C∼B) = (h(C∼B)1 , h(C∼B)2) (2.6.4)
and
h(DR∼DQ) = (h(DR∼DQ)1 , h(DR∼DQ)2) (2.6.5)
resulting from these alleles. Each of these haplotype pairs are assigned haplotype scores
based on their frequencies, as follows:
SH(C∼B) = f(h(C∼B)1) ∗ f(h(C∼B)2) (2.6.6)
SH(DR∼DQ) = f(h(DR∼DQ)1) ∗ f(h(DR∼DQ)2) (2.6.7)
Similarly, each obtained HLA haplotype pair is assigned an allele score SA based on
the individual allele prediction probabilities Sg, as follows:
SA(C∼B) =
1
2
∑
g⊆{C,B}
Sg (2.6.8)
SA(DR∼DQ) =
1
2
∑
g⊆{DR,DQ}
Sg. (2.6.9)
where the summation is over all alleles g that occur in predicted haplotypes. SA(x) is
used to denote overall allele score at the gene x ∈ {A,C,B,DRB1, DQB1}. Note that
the allele score for gene HLA-A is based solely on allele prediction likelihood Sg, that
is
SA(HLA−A) = Sg(HLA−A) (2.6.10)
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We use full gene name HLA-A in the above equation to avoid confusion with allele score
notation represented with A.
To select the most likely pair of haplotypes for a test sample with unknown HLA
alleles, we combine allele and haplotype scores into a weighted score S as follows:
SHLA−A = SA(HLA−A) (2.6.11)
SC∼B = f(SA(C∼B), SH(C∼B)) = (1− δ) ∗ SA(C∼B) + δ ∗ SH(C∼B) (2.6.12)
SDR∼DQ = f(SA(DR∼DQ), SH(DR∼DQ)) = (1−δ)∗SA(DR∼DQ)+δ∗SH(DR∼DQ) (2.6.13)
where δ ∈ [0, 1]. The prediction of HLA-A gene is based solely on the allele score, while
the prediction of HLA-C and HLA-B is based on both C ∼ B allele and haplotype scores,
and the prediction of HLA-DRB1 and HLA-DQB1 is based on both DRB1 ∼ DQB1
allele and haplotype scores.
2.6.3 Results
We perform a thorough evaluation of how global and local haplotype frequencies assist
the prediction of HLA genes, using different δ thresholds and cross-validation.
2.6.4 Data sets
We used HLA and SNP data from the International HapMap project5. This data set
contains 180 individuals of European ancestry (CEU) typed at 6, 300 SNPs in the MHC
region and 6 HLA genes (HLA-A, -C, -B, -DRB1, -DQA1, -DQB1).
We also used SNP and HLA genotype data from the British 1958 Birth Cohort (BC)6
downloaded from the European Genotype Archive7. Genotyping of the BC data was
carried out using Affymetrix 6.0 platform [7]. High resolution typing of five HLA genes
(HLA-A, -C, -B, -DRB1, -DQB1) is obtained using Sequence Specific Oligonucleotide
5 hapmap.ncbi.nlm.nih.gov
6 www.b58cgene.sgul.ac.uk
7 www.ebi.ac.uk/ega
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and Sequence Specific Primer methodologies8. After preprocessing, this data set consists
of 1186 samples of European origin with all 5 HLA genes and 1795 SNPs across the MHC
region.
The haplotype frequencies we used in this study were published in [37]. They contain
7, 987 5-gene haplotypes and their relative frequencies in African, European, Asian and
Hispanic populations. In this study we used European frequencies.
2.6.5 Experimental evaluation
For each data set, we randomly selected 80% of samples to use as a training set and 20%
of samples to use as a test set. We then used the proposed approach to predict the HLA
alleles for all test samples and computed the accuracy of the prediction (for each gene
separately) by comparing the obtained alleles on the two predicted haplotypes with the
true alleles. More precisely, we computed accuracy as follows:
accuracy =
∑N
i=1 |Pi ∩ Ti|
2 ∗N (2.6.14)
where the summation is over all test samples. Pi and Ti are predicted and true alleles
of sample i, respectively, and N is the number of test samples. All experiments are
conducted at the intermediate 2-digit resolution of HLA alleles, and repeated for 10
iterations.
Global haplotype structure
Here we investigate the impact of global haplotype frequencies on the prediction per-
formance. Figures 2.9 and 2.10 show achieved accuracies for data sets HapMap and
BC for all 10 iterations and a range of δ values. The accuracy generally increases with
the addition of haplotype frequencies into the prediction. However, the improvement
in accuracy varies for different HLA genes and for different iterations. This variability
is greater in the HapMap data set, which is likely due to a relatively small sample size
considering the high polymorphism of HLA genes. Lower accuracies are likely to be
achieved for alleles that are under-represented or non-existent in the training data. In
contrast, the BC data set shows less variability in accuracy across different iterations
8 www-gene.cimr.cam.ac.uk/public data/HLA/HLA.shtml
40
Figure 2.9: Accuracy of prediction for each HLA gene in HapMap data set when using
global haplotype frequencies across 10 iterations.
due to its larger sample size. Some variability across different genes is still present; for
instance, the HLA-B gene is predicted with the lowest accuracies. This gene is the most
polymorphic gene in the region, and therefore, the most challenging one to predict.
In order to evaluate the trend with which the accuracy changes with the addition
of haplotype frequencies, we looked at the average increase in prediction accuracy over
all iterations, relative to the accuracy for δ = 0 (haplotype information not included in
prediction). Accuracies for δ > 0 are divided by accuracy for δ = 0 and averaged over
10 iterations, so that the relative increase in accuracy for δ = 0 for all genes is equal to
1. Relative increase different from 1 indicates the factor by which the accuracy changed
from the accuracy at δ = 0. These results are shown in Tables 2.4 and 2.5. The relative
accuracy increases for all genes for δ > 0, that is, with the addition of the haplotype
structure. This increase is the biggest for HLA-DQB1 (max 1.5102) and smallest for
HLA-A (max 1.015) in HapMap data set. Gene HLA-A is farthest away from other
HLA genes, and therefore, benefits the least from the addition of haplotype structure.
Note that the relative increase in accuracy is generally smaller for the BC data set. This
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Figure 2.10: Accuracy of prediction for each HLA gene in BC data set when using global
haplotype frequencies across 10 iterations.
is due to the overall higher accuracies in this data set (> 0.9), which leaves less room
for improvement. It is important to note that there is, however, a steady increase in
accuracies as we add the haplotype structure in both data sets, and for all genes.
Table 2.4: Average relative increase in accuracy when using global frequencies in
HapMap data set as δ increases
δ A C B DRB1 DQB1
0 1.0000 1.0000 1.0000 1.0000 1.0000
0.2 0.9963 1.0195 1.0729 1.0846 1.3727
0.4 1.0148 1.0125 1.0955 1.0912 1.4712
0.6 1.0007 1.0020 1.1061 1.0955 1.4917
0.8 1.0025 1.0020 1.1122 1.0787 1.5069
1 0.9989 1.0038 1.1146 1.0765 1.5102
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Table 2.5: Average relative increase in accuracy when using global frequencies in BC
data set as δ increases
δ A C B DRB1 DQB1
0 1.0000 1.0000 1.0000 1.0000 1.0000
0.2 1.0145 1.0528 1.0173 1.0174 1.0035
0.4 1.0180 1.0616 1.0166 1.0199 1.0046
0.6 1.0175 1.0616 1.0151 1.0203 1.0046
0.8 1.0168 1.0611 1.0151 1.0199 1.0046
1 1.0171 1.0623 1.0173 1.0199 1.0046
Local haplotype structure
Here we investigate the impact of local haplotype frequencies on the prediction accuracy.
Figures 2.11 and 2.12 show the achieved accuracies for data sets HapMap and BC as
δ changes from 0 to 1. Note that, in this approach, the prediction for gene HLA-A is
independent of the parameter δ and therefore, the accuracy at this gene does not change
with δ. Relative increase in accuracy for all genes is shown in Tables 2.6 and 2.7.
Local haplotype frequencies contribute to a steady increase in accuracy across all
values of δ with the maximum increase achieved for δ = 1. This is consistent across
all genes that are in strong linkage disequilibrium, in this case, genes HLA-B and -C,
and HLA-DRB1 and -DQB1. However, when compared against the results obtained by
using global haplotype frequencies, we see that comparable accuracies are achieved, for
a wider range of δ, rather than for only δ = 1. This is important in practical context of
selecting appropriate δ value to predict HLA alleles for any given data set. An additional
benefit of using global haplotype frequencies is that the prediction of HLA-A gene is
also likely to improve using this approach, unlike the case of using local structure.
Table 2.6: Average relative increase in accuracy when using local frequencies in HapMap
data set as δ increases
δ A C B DRB1 DQB1
0 1.0000 1.0000 1.0000 1.0000 1.0000
0.2 1.0000 1.0000 1.0188 1.0191 1.1431
0.4 1.0000 1.0000 1.0400 1.0473 1.2436
0.6 1.0000 1.0054 1.0497 1.0709 1.3908
0.8 1.0000 1.0197 1.0748 1.0663 1.5237
1 1.0000 1.0184 1.1038 1.0750 1.5496
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Figure 2.11: Accuracy of prediction for each HLA gene in HapMap data set when using
local haplotype frequencies across 10 iterations.
Table 2.7: Average relative increase in accuracy when using local frequencies in BC
data set as δ increases
δ A C B DRB1 DQB1
0 1.0000 1.0000 1.0000 1.0000 1.0000
0.2 1.0000 1.0088 1.0046 1.0011 1.0004
0.4 1.0000 1.0235 1.0069 1.0047 1.0007
0.6 1.0000 1.0484 1.0118 1.0094 1.0018
0.8 1.0000 1.0727 1.0181 1.0150 1.0024
1 1.0000 1.0676 1.0046 1.0196 1.0044
2.7 Conclusion
We demonstrate the need to use high linkage disequilibrium in the MHC region to assist
the prediction of HLA alleles. We do this by using haplotype frequencies to show that
adding the frequency information increases the accuracy of prediction. In addition, we
described an improvement of our original method that allows for a more systematic
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Figure 2.12: Accuracy of prediction for each HLA gene in BC data set when using local
haplotype frequencies across 10 iterations.
selection of top predictions. Next, we evaluated the impact of HLA gene dependency on
the prediction of HLA genes from SNP data. We proposed integrating local and global
dependencies among HLA genes into the prediction, and analyzed the advantages and
disadvantages of each.
The results on our data show that the addition of global structure produces a more
robust prediction with respect to parameter δ. Furthermore, adding global haplotype
information improves the prediction of all genes, including the ones that are farther
away from strongly linked local haplotypes, such as gene HLA-A. However, considering
the relatively small sample size of our data, we are hesitant to generalize our findings
on other data sets. The local structure approach may have a bigger impact on larger
data sets that have a better representation of rare alleles. Local linkage between genes
contributes with higher local frequencies to the final prediction score and may help
promote those rare alleles to the top from the initial list of predictions. Also, linkage
patterns differ across populations, and it is widely observed that linkage disequilibrium
in non-African populations extends over longer distances than in Africans [79]. This
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means that shorter haplotypes should have a bigger impact in African populations than
in non-African populations. Since we conducted our study on a data set of European
ancestry, we cannot generalize to data sets of other origins.
We plan to extend our work in the following directions:
1. We intend to conduct a thorough experimental evaluation of the proposed method-
ology. This includes investigation on how experimental parameters impact the
overall performance of the method. Some of these parameters are: the number
of top predictions k, the number of SNPs used in prediction m, and the width of
genomic region around each HLA gene from which the SNPs are used in prediction.
2. Our current implementation of the base classifier is computationally expensive
and cannot handle large numbers of SNPs. In the future, we plan to use a more
scalable classifier that will handle larger numbers of SNPs and therefore make
better initial predictions of HLA alleles.
3. We use a weighted sum function to combine allele and haplotype scores into a
final score. We intend to investigate several other functions and their impact on
prediction performance of the algorithm.
4. We intend to integrate this framework with a more sophisticated method for gene-
independent HLA prediction that produces somewhat higher accuracies.
5. We plan to investigate the application of this framework on a data set of non-
European origin. As demonstrated on the BC data set, there is little room for
improvement on large data sets of European origin, since high accuracies are
obtained even without the addition of HLA haplotype information. However,
data sets of non-European origin are less widely available and are of much smaller
sample size. As such, they present a bigger challenge when it comes to prediction of
HLA genes and could benefit from the gene dependency information. In addition,
linkage disequilibrium patterns differ in different populations, and the addition of
dependency information into the HLA prediction may be even more beneficial for
a non-European population.
6. In this study we used haplotype frequencies published in [37] and generated from
a relatively small sample of about 10K individuals. In the future we intend to
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use more recently published haplotype frequencies generated from a much larger
sample size (∼ 6M individuals) and encompass more populations (21 detailed
populations) [20]. Using these frequencies may result in higher accuracies as they
more adequately represent a population (e.g. using African Black population
frequencies published in [20] may enhance predictions for YRI population used
in this study because they match the YRI population more closely than African
American frequencies published in [37]).
Chapter 3
Measuring Ambiguity in HLA
Typing Methods
3.1 Introduction
The high polymorphism in HLA presents a challenge when it comes to typing HLA genes.
The typing has historically been performed using serological antibody tests, which are
able to identify HLA protein variants on the surface of the cell using antigen-specific
antibodies [9]. Serology has been widely replaced with DNA-based typing methods due
to its inability to identify all specific products of the HLA alleles. It is shown that in
order to improve the clinical outcome of HSCT from an unrelated donor, it is essential
to identify and match patient’s and donor’s HLA genes at the allele level [46, 57, 66].
DNA-based methods identify HLA alleles by interrogating the nuclear DNA sequence
and can result in different levels of ambiguity depending on typing methodology or test
kits used. HLA typing methods, their corresponding formats and abbreviations used
in this chapter are given in Table 3.1. Some of the widely used molecular methods for
typing HLA genes, as defined in American Society for Histocompatibility and Immuno-
genetics Standards (ASHI), are a nucleic acid-based typing method using sequence-
specific oligonucleotide hybridization (SSO) [25, 48], a nucleic acid amplification-based
typing method using sequence-specific priming (SSP) and sequence-based typing (SBT)
[65]. Even though DNA-based technology improved identification of specific alleles,
HLA typing results reported by testing laboratories are still commonly resolved to a
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certain level of ambiguity, rather than to an exact allele assignment [23]. Exact high
resolution HLA typing can be costly and laborious with the large and rapidly growing
number of described HLA alleles, which sometimes cannot be easily distinguished with
existing high-throughput typing methods. Ambiguous allele assignments are produced
either due to failure to interrogate all polymorphic positions, or due to a lack of phase
between polymorphisms within a locus because of diploid sequence reads (or both).
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Typing
Method
Description Abbr. Example
Typing
Serology
Identifies HLA
protein on the
cell surface using
antigen-specific
antisera
Broad antigen typing
SERO
A9, A28
Split antigen typing A24, A68
DNA
Identifies HLA
alleles by
interrogating
DNA
Allele fam-
ily level
Two-digit
resolution
DNA2 A*24:XX,
A*68:XX
Sequence
specific
oligonu-
cleotides
Allele codes SSO A*24:AER,
A*68:GM
AER=02/03/
04/05
GM=01/02/
03/04/05
Sequence
based
typing
Single-pass
SBT
SBT A*24:02,
A*68:01 or
A*24:03,
A*68:01 or
A*24:04,
A*68:01 or
A*24:05,
A*68:01
High reso-
lution
Exact alle-
les
HR A*24:02,
A*68:01
Table 3.1: HLA typing formats reported by NMDP contract typing laboratories.
In HSCT the selection of donors for a patient in need of a transplant is based
primarily on HLA matching, and the lower the ambiguity of typing the easier it is to
determine the probability of allele level match during the donor search [26]. In order
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to facilitate rapid identification of matched donors for HSCT several methods have
been proposed to infer unknown phase and allele assignment [19, 35]. They typically
employ statistical methods and the unique properties of the HLA region, such as its high
linkage disequilibrium, in order to estimate haplotype frequencies and predict the most
likely haplotype assignment for an individual with an HLA typing consisting of a set
of ambiguous allele pairs. HLA typing with less ambiguity on average gives fewer high-
probability phased high resolution haplotypes. We aim to measure per-locus ambiguity
resulting from several HLA typing formats across four continental populations using an
information theory-based measure, Shannon’s entropy [71].
Some previous work has been done in measuring typing ambiguity, first a measure
developed by Helmberg et al. [22] and more recently, the first application of Shannon’s
entropy to this problem by Cano [8]. Helmberg proposed a characterization of HLA
typing kits using a frequency inferred typing (FIT) index. A FIT index describes the
probability of correct allele pair assignment for an ambiguous typing result, and is
calculated as the negative log of the probability of a wrong allele pair prediction. This
probability is equal to the sum of products of all allele pairs that share the same typing
pattern as the selected pair. The limitation of the FIT index is that it does not take
into account the distribution of allele frequencies beyond the most likely assignment.
The concept of measuring ambiguity in HLA typing using entropy was first presented
by Cano in [8]. They used population-specific allele frequencies and several SSO typing
examples to demonstrate the utility of the measure.
Both previous typing ambiguity studies used allele frequencies in their computations
and, as we will later show, fail to demonstrate the advantage of linkage disequilibrium
information contained in haplotype frequencies when it comes to reducing ambiguity
and improving predictions of patient-donor matching. We use haplotype frequencies
and show that the ambiguity is reduced considerably compared to using allele frequen-
cies, proving that this advance in strategy for identifying matched donors has had a
significant positive impact. In addition, we take this methodology further and use it
to evaluate several different typing methods, and directly compare them with respect
to the inherent ambiguity measured by entropy. To measure the impact of the typing
method ambiguity in more relatable terms, we also developed a measure we call Con-
firmatory Typing (CT) Mismatch Rate, which gives the average probability across a
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set of patients that a mismatch would occur between the patient and donor when a
high resolution confirmatory typing is performed on the ambiguously-typed donors in a
uniformly-typed registry.
We show that entropy can be used to objectively compare methods of HLA typing
to each other in terms of the information they provide, in the context of each individual
population. Our results show that intermediate-resolution single-pass sequence-based
typing (SBT) reported in genotype list format contains the least ambiguity and, there-
fore, the most certainty in allele prediction across all populations. We examine the
benefit of using haplotype frequencies in entropy calculations versus allele frequencies.
Neighboring HLA and non-HLA genes are highly correlated and major efforts have been
directed at describing linkage disequilibrium (LD) across the region [11, 44, 80]. When
certain alleles occur together generally due to linkage disequilibrium between them,
some ambiguity can be inferred away using this linkage information, which is inherently
contained in haplotype frequencies. Our results show that using population haplotype
frequencies immensely reduces the ambiguity present in HLA typing. This demonstra-
tion allows HLA typing methods to be objectively evaluated in the practical context of
a matching algorithm that uses haplotype frequencies to predict probabilities of allele
level matches between a patient and list of potentially matched donors. It is hoped that
this analysis can lead to data-driven HLA typing resolution strategies for registry donor
and cord-blood unit (CBU) typing.
3.2 Materials and Methods
3.2.1 Typing formats
Before DNA-based HLA typing methods were developed, serological testing identified
sets of alleles with similar reactivity. Two-digit level resolution is the lowest HLA typing
resolution reported by typing laboratories today. For these lower-resolution formats,
alleles in the same family as A*01:01 are reported as A1 using serological methods
(abbreviated SERO), or as a truncated result of intermediate-level DNA-based typing
(referred to as DNA2 in this text) as A*01 or A*01:XX.
A commonly used intermediate-resolution format is the one using NMDP allele codes
[5]. Sequence-specific oligonucleotides (SSO) typing results are reported in this format
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for this study, where each allele code represents two or more alleles. For example, an
allele reported as A*01:AB can be either A*01:01 or A*01:02, and an allele reported as
A*26:JGSJ can be any of the following three: A*25:13, A*26:01, A*26:52. Therefore, the
number of combination for an ambiguous allele pair reported in this format increases
multiplicatively, that is, the allele pair (A*01:AB, A*26:JGSJ) will have six possible
pairwise combinations (A*01:01, A*25:13 or A*01:01, A*26:01 or A*01:01, A*26:52 or
A*01:02, A*25:13 or A*01:02, A*26:01 or A*01:02, A*26:52). Ambiguous sequence
based typing (SBT) is reported in the format of genotype lists for this study, that is, in
the form of several possibilities for pairs of alleles an individual carries (A*24:02,A*68:01
or A*24:03,A*68:01 or A*24:04,A*68:01). Because in single-pass SBT results, some
ambiguous genotype lists cross several allele families, allele codes could be used to
represent all typing results. However, genotype list representation has the advantage of
showing that some genotype possibilities, added implicitly when compressing to allele
code format, are not possible.
3.3 Data Sets
3.3.1 Haplotype frequency data
We used high-resolution haplotype frequencies generated from unrelated donors from the
National Marrow Donor Program (NMDP) database for four principal population cate-
gories defined by the United States census: African American (AFA), Caucasian (CAU),
Hispanic (HIS) and Asian/Pacific Islander (API) [37]. These categories are referred to
as self-described ethnic groups (SIRE), as they are selected by individuals from the
NMDP race/ethnicity questionnaire at donor registration. NMDP develops and main-
tains a repository of several million HLA-typed donors to facilitate hematopoietic stem
cell transplantations among unrelated individuals. Table 3.2 shows populations used
and the number of haplotypes, HLA-A, -B, and DRB1 alleles within each population.
3.3.2 Simulated typing results
To generate simulated typings for different HLA typing methods, we first sampled 2
haplotypes from a high resolution population haplotype frequency data set [37]. These
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Population Description # of 3-locus
Haplotypes
# of HLA-
A Alleles
# of HLA-
B Alleles
# of HLA-
DRB1 Alle-
les
AFA African
American
3,049 68 107 59
CAU Caucasian 5,214 97 158 70
API Asian-
Pacific
Islander
2,157 56 102 62
HIS Hispanic 3,102 75 138 62
Table 3.2: HLA haplotype frequency data used in this study. This table shows
four population groups and their corresponding haplotype frequencies used for the simu-
lation of samples in this study. The data contains frequencies for three-locus haplotypes
(A B DRB1). The table also shows the number of unique HLA-A, HLA-B and HLA-
DRB1 alleles present in the haplotypes for each population group.
sampled haplotypes were then ”rolled up” from the high resolution typing to a lower
resolution typing to emulate how the typing would have appeared using various typing
methods. For example, a high resolution haplotype pair with the format:
A ∗ 23 : 01 ∼ B ∗ 18 : 01 ∼ DRB1 ∗ 07 : 01, A ∗ 30 : 02 ∼ B ∗ 58 : 02 ∼ DRB1 ∗ 12 : 01
would be rolled up into lower resolution typing (in this case serology) as follows:
A23, A30;B18, B58;DR7, DR12.
Note that the high-resolution haplotypes contain neither phase nor allele ambiguity,
while the lower resolution typing contains both. Simulated typings of 1,000 individuals
were generated for the four broad population groups (AFA, API, CAU, HIS) and four
different typing methods (SERO, DNA2, SSO, SBT).
While we use HLA nomenclature Version 3 style formatting to describe HLA alleles
in this chapter, we simulated the four typing methods for Version 2.28 of the IMGT-HLA
database, to more closely match the time in which the typing results used to generate
the haplotype frequencies were reported. To generate serologic typing (SERO), we used
the HLA dictionary, which allows each HLA allele to be mapped to a serologic equiv-
alent (e.g. B*15:02 maps to B75) [24]. To map alleles to DNA 2-digit (DNA2), we
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removed all fields from the HLA typing but the first field describing the allele family
(e.g. B*15:02 becomes B*15:XX). To simulate SSO typing, given detailed information
on the probes present in each SSO kit and the IMGT/HLA database of allele sequences,
probe hit tables were computed for all possible combinations of described alleles. Each
pair of alleles was mapped to the set of allele pairs that had identical probe hit pat-
terns, then the typing was compressed to NMDP allele code format. For HLA-A and
HLA-B loci we used kits described at the 12th International Histocompatibility Work-
shop [31], and for HLA-DRB1 locus we used a kit described at the 11th International
Histocompatibility Workshop [48, 47]. SBT simulation mapped allele pairs to a list of
ambiguous genotypes with identical heterozygous sequence in exons 2 and 3 published
by IMGT-HLA (http://www.ebi.ac.uk/imgt/hla/ambig.html) and reported the typing
in the genotype list format.
3.3.3 Shannon’s entropy
Shannon’s entropy quantifies the amount of uncertainty or disorder associated with
a particular system, and is widely used in a variety of applications, such as genetics
[30, 33, 83], data mining [51], molecular biology [67], and imaging [69]. In information
theory, entropy is used to measure uncertainty associated with a random variable. Here
we used entropy to measure and compare ambiguity associated with the results of various
HLA typing methods. Given an ambiguous genotype X, Shannon’s entropy (H) is
defined as:
H(X) = −
∑
x∈X
p(x)log(p(x)) (3.3.1)
Where p(x) is the relative frequency of a single-locus or multi-locus high resolution
genotype x. Entropy can be thought of as the ambiguity or impurity present in a system
of interest. If, in a set of typing results for one individual, all of them are equally likely
(frequent) then the entropy is the highest as we have the least information to choose
the most likely real genotype.
To illustrate the usefulness of entropy in measuring typing ambiguity we show an
example of two typing results with the same number of ambiguities (Table 3.3). Both of
these ambiguous typings have six possible pairs of alleles, however, one of them is more
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pure with respect to the frequency distribution of these combinations, and therefore
has a lower entropy (0.014 versus 1.676, with a mean entropy of 0.54 for ambiguous
typing results in this sample). Note that entropy depends on the size of the set as well
as the distribution of frequencies in the set. If Hn is the entropy of n typings, then it
is maximal for outcomes of equal frequencies, that is, Hn(p1, .., pn) 6 Hn(1/n, .., 1/n),
and it increases with the number of equally frequent typings, that is, Hn(1/n, .., 1/n) <
Hn+1(1/(n + 1), .., 1/(n + 1)). Therefore, depending on the distribution of frequencies
and the number of possible alleles for an ambiguous allele pair, typing results can have
drastically different entropies.
Typing 1 Typing 2
Ambiguities Relative
Fre-
quency
−plog(p) Ambiguities Relative
Fre-
quency
−plog(p)
B*5702/B*5801 0.0923 0.3172 DRB1*0301/DRB1*1301 0.9989 0.0016
B*5702/B*5802 0.0832 0.2985 DRB1*0301/DRB1*1327 0.0005 0.0056
B*5702/B*5804 0.0001 0.0016 DRB1*0304/DRB1*1301 0.0002 0.0024
B*5703/B*5801 0.4331 0.5229 DRB1*0304/DRB1*1327 0.00 0.00
B*5703/B*5802 0.3907 0.5297 DRB1*0306/DRB1*1301 0.0004 0.0044
B*5703/B*5804 0.0006 0.0063 DRB1*0306/DRB1*1327 0.00 0.00
H = 1.676 H = 0.014
Table 3.3: An illustration of two ambiguous typing results with the same
number of possible allele sub-types and different level of ambiguity as mea-
sured by entropy. Shown here are typing results for two simulated subjects. They
each have six ambiguous sub-types (allele-pairs), but very different entropies. Typing
1 has entropy H = 1.676 and Typing 2 has entropy H = 0.014. Both of these typings
come from the same population sample (African American) in which the mean allele
entropy for this simulated sample is H = 0.54.
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3.3.4 Entropy calculations using HLA frequencies
The HLA haplotype frequencies we used in this study were estimated by the expectation-
maximization algorithm (EM) described in [29]. To obtain the allele frequency of allele
Aj from haplotype frequencies we simply summed the frequencies over all haplotypes
in the given population group that included that allele, that is:
p(Aj) =
n∑
i=1
p(Ai ∼ Bi ∼ Di)I(Aj) (3.3.2)
where A, B, and D are typed loci, N is the total number of haplotypes and I(Aj) is
an indicator function that takes value of 1 (0) when a haplotype contains (does not
contain) allele Aj . For each ambiguously typed locus, we generated all possible pairs of
alleles (AiAj), and computed their respective frequencies as follows:
p(AiAj) = p(Ai)p(Aj). (3.3.3)
In the first set of experiments, we used these allele pair frequencies derived from allele
frequencies in entropy calculations to compute allele entropy for each locus.
To compute locus entropy using haplotype frequencies, or haplotype entropy, we
do the following. For each ambiguously typed three-locus genotype, g = (AaBbDd),
we generated all possible haplotype pairs and their frequencies using imputation as
described in [29]. To compute the entropy of a particular locus, we obtained frequencies
for each unique allele pair on that locus, say AiAj , by summing over all frequencies
of haplotype pairs generated for the given genotype, that contain the given allele pair,
that is
p(AiAj) =
N∑
k=1
p(Ak ∼ Bk ∼ Dk, Ak ∼ Bk ∼ Dk)I(AiAj) (3.3.4)
where N is the number of generated haplotypes and I(AiAj) is an indicator function
that takes value of 1 (0) when a haplotype pair contains (does not contain) allele pair
(AiAj). We then used these allele pair frequencies derived from haplotype frequencies
to compute haplotype entropy in the same manner as described for the case of allele
entropy.
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As a side note, an ambiguous typing with many possible alleles at each locus can
result in a large combinatorial number of possible haplotype pairs. Given a fully het-
erozygous case of three-locus un-phased genotype with ni, i ∈ 1, 2, 3 possible alleles at
each locus, the number of possible haplotypes is equal to
∏L
i=1 ni and the number of
phased haplotype pairs is equal to 2L−1
∏L
i=1 ni, where L is the number of loci, in this
case L = 3. In these equations we assume the heterozygosity of all loci, since the esti-
mated numbers would be smaller for a homozygous case in which some HLA loci have
the same alleles on both chromosomes. For typings including five or six HLA loci and
high allelic ambiguity, the number of phased haplotype pairs can grow into billions.
3.3.5 Confirmatory typing mismatch rate
Besides objective evaluation of typing methodologies employed in typing the HLA re-
gion, using the entropy approach to measure ambiguity has another application from
a clinical perspective, namely its direct relationship to confirmatory typing (CT) mis-
match rates. For a given patient, high resolution CT is done to confirm the patient-donor
match from a selected set of donors. A case where the high resolution typings mismatch
is called a CT mismatch. We compute CT mismatch rates on the same simulated donor
sample by comparing the ambiguous typing and the exact haplotype pair that was used
to generate that ambiguous typing. As described in a previous section, each ambiguous
genotype can generate multiple HLA haplotype pairs, the true one being the haplotype
pair we used to simulate the ambiguous typing. The CT mismatch rate for each locus is
computed as the summation of frequencies of all allele pairs (computed using Equation
3.3.4) that do not match the corresponding allele pair of the haplotypes used to simulate
the donor typing. This is the probability that a selected donor will not be the exact
match for the given patient.
3.4 Results
Locus entropies obtained for SBT, SSO, allele family level DNA2 and SERO typing
methods are shown in Table 3.4, averaged over the three loci (HLA-A, -B, -DRB1) and
within each population using allele frequencies (allele entropy). SBT had the lowest
entropy and therefore the least inherent ambiguity when it comes to resolving HLA
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alleles at the locus level, across all populations. As expected, serology produced the
lowest resolution typing and had the highest entropy. SSO typing was far more am-
biguous than SBT across all evaluated datasets, reflecting both SBT’s more complete
coverage of polymorphic positions in the exons and the benefits of using genotype list
format for SBT typings rather than the NMDP allele code format we used for SSO.
Figure 3.1 shows the average allele entropy for each locus for AFA, CAU, HIS and API
population groups. The ranking of the typing methods with respect to the least amount
of ambiguity across all populations was: SBT, SSO, allele family level DNA2, SERO.
AFA API CAU HIS
SBT 0.0354 0.0668 0.0766 0.0787
SSO 0.2974 0.5247 0.49 0.5004
DNA2 1.8501 2.023 1.056 2.1709
SERO 1.7735 2.2282 1.6548 2.9471
Table 3.4: Average allele entropy for all typing methods and all population
groups. This table shows the locus entropy for SBT, SSO, DNA2 and SERO typing
methods for all four populations using allele frequencies and averaged over the three
loci, HLA-A, -B, -DRB1.
When we used haplotype instead of allele frequencies, we got the same ambiguity
ranking (Table 3.5) for average locus entropies obtained for SBT, SSO, and DNA2 typ-
ing methods (haplotype entropy). However, a dramatic decrease in entropy occurred
across all typing methods when we used haplotype instead of allele frequencies. For
example, the allele entropy of SSO typing in Caucasian group is 0.49 while the haplo-
type entropy is an order of magnitude lower at 0.0477. This decrease is due to some
ambiguity being resolved by LD information provided in haplotype frequencies, and is
successfully captured by Shannon’s entropy. Figure 3.2 shows the average haplotype
entropy for each locus and each population separately. The LD information contained
in haplotype frequencies reduces the entropy considerably compared to only using allele
frequencies, demonstrating that this strategy for identifying matched unrelated donors
has a significant positive impact. Figure 3.3 shows the comparison between allele and
haplotype entropies for each typing method and within each population group. This
result also demonstrates the utility of imputation algorithms that generate population
haplotype frequencies to more accurately predict the likelihood of allele match for stem
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cell registry matching algorithms.
AFA API CAU HIS
SBT 5.30E-04 0.0031 0.002 0.005
SSO 0.0923 0.2074 0.0477 0.1195
DNA2 1.2685 1.6219 0.7277 1.7633
SERO 1.2488 1.3889 0.7205 1.7495
Table 3.5: Average haplotype entropy for all typing methods and all popu-
lation groups. This table shows the locus entropy for SBT, SSO, DNA2 and SERO
typing methods for all four populations using haplotype frequencies and averaged over
the three loci, HLA-A, -B, -DRB1.
To demonstrate the impact of typing method ambiguity in a clinical setting we
computed CT mismatch rates, which give the average probability that a mismatch
would occur between a patient and donor when high resolution confirmatory typing is
performed on the ambiguously typed donors in a uniformly typed registry. CT mismatch
rates computed on the same sample of 1000 simulated donors are shown in Table 3.6. We
can see a direct correlation between CT mismatch rates and entropy computed across
typing methods dimension (Pearson’s correlation coefficient between CT mismatch rates
and haplotype entropy is = 0.96, and between CT mismatch rates and allele entropy is
= 0.92). For SSO typing we found an average haplotype entropy of 0.05 and a 1.31% CT
mismatch rate, while for SBT typing, we found an average haplotype entropy of 0.002
and a 0.08% CT mismatch rate, in the CAU population group. In a hypothetical donor
registry with uniformly typed donors, choosing a typing method with smaller entropy
across a given population may result in smaller mismatch rates during the confirmatory
typing phase and more certainty in a selected set of donors. This CT mismatch rate
gives us a more intuitive clinical interpretation of these entropy scores. An important
assumption when computing CT mismatch rates is that all donors in the registry are
typed with the same method. This is generally not the case, and as donors with better
typing accrue, CT mismatch rates are expected to decrease over time.
3.5 Discussion
We have shown that entropy can be used to objectively compare methods of HLA typing
in terms of the information they provide. The calculation of per-locus entropy using
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AFA API CAU HIS
SBT 2.0135e-04 9.3340e-04 8.0012e-04 0.0015
SSO 0.0236 0.0530 0.0131 0.0324
DNA2 0.3792 0.4286 0.4069 0.4366
SERO 0.3755 0.3724 0.1957 0.4334
Table 3.6: Confirmatory typing (CT) mismatch rates for all typing methods
and all population groups. This table shows the expected confirmatory typing (CT)
mismatch rates for SBT, SSO, DNA2 and SERO typing formats and four populations
averaged across all three loci (HLA-A, -B, DRB1). CT mismatch rates describe the
probability that a mismatch would occur between a patient and donor during high
resolution confirmatory typing on the ambiguously typed donors in a uniformly typed
registry.
haplotype frequencies has a direct application in measuring the impact of using haplo-
type frequencies to predict the likelihood of allele match for stem cell registry matching
algorithms. The LD information contained in haplotype frequencies reduces the en-
tropy considerably compared to using allele frequencies, showing that this strategy for
identifying matched donors has a significant positive impact. No objective quantita-
tive comparisons between SBT and SSO methods have been available to date. Typing
laboratories may choose SSO methods over SBT methods primarily based on cost sav-
ings achieved due to easier set-up, staff training, pre-packaged kits, and automation.
However, these apparent cost savings may have a price of higher typing ambiguity. We
have shown that single-pass SBT typing performs far better at distinguishing alleles
compared to mid-1990’s-era SSO typing. However, currently available SSO typing kits
used for recruitment typing have more oligonucleotide probes and thus are able to dis-
tinguish more alleles, which may result in entropy as low as that of single-pass SBT.
Given equal cost, registries should utilize laboratories that employ HLA typing meth-
ods that achieve lower entropy for their population. Our objective measure of typing
ambiguity can be advantageously applied to the continual improvement of all methods
of HLA typing. Design of SSO kits could be done in silico using population haplotype
frequencies and sequence information from the IMGT-HLA database [62]. SSO kits are
designed to distinguish between the most common alleles in a population. In United
States and Europe, populations of European origin predominate, and therefore some
alleles common in minority populations may not be distinguished in some kits. Given
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a fixed number of probes, the SSO kit that provides the lowest entropy in a population
could be considered optimal.
As new alleles are discovered, SSO kits are often altered to add more probes so
that typing results do not cross allele families and thus meet current guidelines for
acceptable recruitment typing. These new probes will not decrease entropy appreciably
as the frequency of a newly discovered allele tends to remain very low.
Because of sample size limitations, many of the rare alleles described in IMGT-HLA
were not observed in our samples. However, rare alleles do not have a significant impact
on entropy calculations. Owing to the logarithmic nature of Shannon’s entropy, an allele
with a very small frequency p contributes plog(p) to the resulting entropy. This quantity
approaches zero for very small values of p. More formally, limp→0 plog(p) = 0. This
property of the entropy guarantees that potential underestimation of frequencies of rare
alleles not included in the population groups in Table 3.2 will only slightly underestimate
the typing ambiguity. Larger frequency-generating sample sizes available in the future
will serve to eliminate this issue.
Our methods of HLA typing method evaluation can also be applied to next-generation
sequencing technologies. Recently the Roche 454 sequencing platform has been em-
ployed for HLA typing in research rather than recruitment [4, 73]. The 454 platform has
relatively longer read lengths that can clonally type entire exons without intra-exonic
phase ambiguity. However, intronic regions are not amplified by this platform, thus
the system lacks the inability to phase across exons leading to some remaining geno-
typic ambiguity, which would be reflected in entropy calculations. Meanwhile, other
next-generation sequencing platforms more commonly used for whole genome sequenc-
ing use a shotgun approach for sequence coverage that includes intronic regions of HLA
genes [68]. The Illumina platform uses short reads and high read depth, and there is
a potential for HLA typing ambiguity to vary between sequencing runs on the same
sample because of differences in read coverage, and thus success with assembly [81].
With the ambiguity of current SBT methods caused by the reading of heterozygous
sequence from two chromosomes simultaneously, a future technology that would allow
for a single chromosome to be read clonally could eliminate haplotype ambiguity [56]. It
is important to note that many genome-wide studies in practice do not make HLA allele
calls because the polymorphism of the HLA system requires specialized bioinformatics
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analysis unique to these genes [49].
A consideration specifically related to the HLA typing method is the representation
of the ambiguous allele data derived from the HLA typing, which was also measured
using entropy. The 2-digit DNA typing resolution is in practice a result of incomplete
reporting of SSO, SSP, or SBT typing data. The higher entropy of this type of data
shows the value in reporting the complete information available from the HLA typing
platform rather than rounding to the allele family level. The genotype list representation
yields a slightly lower entropy than the NMDP allele code representation. Genotype
list representation allows for the exclusion of some genotypes that have been ruled out
by the HLA typing method, but would still be included in the Cartesian product of the
alleles listed in the NMDP allele codes.
Note that, in some populations, the HLA-B locus presents higher values of entropy
when typed using 2-digit DNA methods than when typed at the serological level (Figure
3.1). This is likely due to the fact that some 2-digit DNA allele families contain alleles
from multiple serologically defined categories. For example, serological antigens exist
to split alleles in the HLA-B15:XX family into B62, B63, B75, B76 and B77, and
HLA-B40:XX family into B60 and B61, while 2-digit DNA typing does not distinguish
between them.
This analysis provides a path for defining acceptable HLA typing for recruitment
as minimum requirements for entropy scores as a measure of typing ambiguity and for
HLA data representation guidelines as a way to ensure that genotype lists are reported.
Single-pass or highly automated SBT can result in HLA typings that cross allele families,
which does not meet current minimum standards for recruitment typing at NMDP, yet
we show that it provides a high-quality low-entropy HLA typing. In fact, we had
to use the genotype list representation for the simulation of single-pass SBT typings
because some allele combinations result in HLA typings for which no NMDP allele codes
have been created due to required minimum standards that HLA allele codes do not
generally cross allele families [21]. Requiring laboratories to resolve ambiguous alleles in
SBT to meet current NMDP requirements can significantly increase cost, but does not
significantly lower entropy. Developing a standard for laboratory reports of typings that
cross allele families would thus enable a reduction in cost of recruitment typing without a
reduction in quality. We observe variation in entropy for the same HLA typing method
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between populations and loci. For example, Figure 3.3 shows lower average entropy
of SSO typing results in the CAU sample than in the HIS sample. Some variation is
attributed to differences in frequency-generating sample size for a particular population
group (in this example simulated Caucasian typings are generated from a larger pool of
haplotype frequencies than Hispanic typings, due to a larger availability of Caucasian
donors in the registry). The remaining entropy differences can be attributed to the
nature and magnitude of HLA genetic diversity in the same group (one can expect HIS
population group to be more broadly defined and hence more genetically diverse). The
resulting entropy can also depend on LD patterns, the location and number of DNA
polymorphisms, and the shape of the allele frequency distribution in the populations.
In addition to absolute differences in entropy between populations, we also observed
differences between population groups in the effectiveness of using haplotype frequencies
in decreasing haplotype entropy. Having higher levels of LD can improve the predictive
capability of haplotype frequencies, and so African population samples with lower LD
could have higher entropy than European populations, with higher LD, for this reason.
In the opposite direction, higher HLA diversity would lead to higher entropy in African
population samples than in European samples. The API sample may have relatively
higher entropy than other population samples because the API frequency distribution
constitutes an average of the frequency distributions of multiple distinct populations,
and thus may be skewed more towards rare types than other populations in this study.
If API entropy were evaluated using more detailed race subcategories (e.g. Japanese,
Korean, Filipino, etc.), we would expect lower entropy values because the HLA diversity
of each respective sub-region would be lower. The size of the population sample used
to generate haplotype frequencies also plays a role in the entropy calculations in that
a relatively larger sample, as we had for CAU compared to the other races, would give
higher entropy. Because of these multiple confounding factors affecting entropy, we
urge caution in using entropy as a measure to compare the HLA characteristics between
samples of different ancestry. There are some caveats in that the simulation framework
implicitly has no sampling error or estimation error in the haplotype frequencies. In
practice, uncertainty in the frequency estimates will lead to higher entropy, so our results
should be treated as a practical lower bound.
For interpretation of between-locus entropy differences, we turn to the history of
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HLA nomenclature in that the allele families and serologic types were defined primarily
using European samples. The naming of allele families was based loosely on serologic
categories, and at some point in history newly discovered serologic patterns were no
longer used to split up allele families. The discovery of new alleles also has an impact
on entropy in that some populations have not been well-characterized for HLA and
some individuals may have as yet un-described alleles that can result in some hidden
entropy. In evaluating entropy at the locus level, we see that at the allele family level,
the HLA-DRB1 locus has a higher entropy than HLA-A and HLA-B loci. The number
of allele families defined for HLA-A and HLA-B is higher than that of HLA-DRB1,
giving a lower entropy for typing resolution at the 2-digit or serologic levels, all else
being equal.
Stem cell registries have been accruing HLA typing results for over 25 years, with
continual advancement in typing methods during this period. The proportion of donors
typed by each method changes over time in a searchable registry due to new donor
recruitment, roll-off of donors exceeding the maximum age, reporting of primary HLA
data, prospective typing, and high resolution typing on behalf of patients. With analysis
of changes in HLA typing data for each donor over their time on the registry, it becomes
possible to chart decreasing entropy in HLA typing over time and determine which
typing methods were primarily responsible for this decrease. Entropy could also be
applied as a selection factor for prospective typing projects in which some donors are
upgraded to lower ambiguity typings.
In summary, the application of Shannon’s entropy as a measure of HLA typing
ambiguity has benefits throughout the lifecycle of HLA typing: in reagent design, lab
reporting standards, donor recruitment typing guidelines, and registry matching algo-
rithm performance evaluation.
65
Figure 3.1: Average allele entropy. This figure shows locus entropies obtained for
SBT, SSO, DNA2 and SERO typing formats, within each population and for three HLA
loci using allele frequencies, that is, the allele entropy. The four panels correspond to four
populations: AFA (African American), API (Asian-Pacific Islander), CAU (Caucasian)
and HIS (Hispanic), respectively, from left to right, top to bottom. The y-axis shows
entropy averaged across 1000 simulated donor typings, and the x-axis corresponds to
the HLA locus that the entropy is measured for (HLA-A, HLA-B and HLA-DRB1). The
color represents the typing methods used for typing: SBT (single pass sequence-based
typing), SSO (sequence-specific oligonucleotides), DNA2 (two-digit allele family level
DNA-based typing) and SERO (serological typing).
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Figure 3.2: Average haplotype entropy. This figure shows locus entropies obtained
for SBT, SSO, DNA2 and SERO typing formats, within each population and for three
HLA loci using haplotype frequencies, that is, the haplotype entropy. The four panels
correspond to four populations: AFA (African American), API (Asian-Pacific Islander),
CAU (Caucasian) and HIS (Hispanic), respectively, from left to right, top to bottom.
The y-axis shows entropy averaged across 1000 simulated donor typings, and the x-axis
corresponds to the HLA locus that the entropy is measured for (HLA-A, HLA-B and
HLA-DRB1). The color represents the typing methods used for typing: SBT (single
pass sequence-based typing), SSO (sequence-specific oligonucleotides), DNA2 (two-digit
allele family level DNA-based typing) and SERO (serological typing).
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Figure 3.3: Comparison of average per-locus entropies obtained from allele
and haplotype frequencies. This figure shows the comparison between allele entropy
and haplotype entropy computed for four typing methods: SBT (single pass sequence-
based typing), SSO (sequence-specific oligonucleotides), DNA2 (two-digit allele family
level DNA-based typing) and SERO (serological typing), respectively from left to right.
Allele entropy was computed using allele frequencies (AF) and genotype entropy was
computed using haplotype frequencies (HF). The y-axis shows the average entropy val-
ues, and the x-axis shows the four continental populations for which the entropy was
computed: AFA (African American), API (Asian-Pacific Islander), CAU (Caucasian)
and HIS (Hispanic), respectively. In all figures, the locus entropy is averaged across the
three loci, HLA-A, -B, -DRB1.
Chapter 4
SNP-based Prediction From
Ambiguous HLA Data
4.1 Introduction
The typing of HLA alleles is generally performed using DNA-based assays that are
not always able to precisely identify the alleles present in the tested sample. Exact
allele-level HLA typing can be costly and laborious with the large and rapidly growing
number of described HLA alleles. Some of the widely used molecular methods for typing
HLA genes are sequence-specific oligonucleotide (SSO) hybridization, sequence-specific
primer (SSP) amplification and sequence-based typing (SBT) [52].
While the typing methodology evolved over time and will evolve further, the majority
of a stem-cell registry data still consists of ambiguous HLA assignments [20]. Ambiguity
at a single HLA gene comes in two forms: allele ambiguity, where the polymorphisms
that distinguish alleles are not interrogated by the typing system, and phase ambiguity,
which results from the inability to establish chromosomal phase between identified poly-
morphisms. All HLA data obtained using current typing methodologies comes without
phase, that is, contains phase ambiguity. The Be The Match registry contains HLA
typing of approximately 10 million donors as of this year. All volunteer donors were
typed for at least HLA-A and -B when they joined the Registry. Most donors were
typed using serologic methods until 1997, when an initiative to use DNA-based testing
was implemented [29]. Starting in 1992 many new volunteers were also typed at the
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Figure 4.1: SNP-based prediction of HLA alleles: proposed approach and related work.
HLA-DRB1 gene. Over time the HLA DNA-based testing has incorporated additional
genes, and the resolution has increased from low to intermediate and high. Even though
the typing quality has increased for new donors, in order to utilize the huge amounts of
historical HLA data in the Registry operations or research, we must develop algorithms
that can successfully learn from ambiguous data.
The described allele and phase ambiguity found in most HLA data sets today
presents a challenge to current SNP-based methods for prediction of HLA alleles, since
they require non-ambiguous data. A way to obtain high-resolution HLA alleles from
ambiguous data is to use one of the existing methods for resolving ambiguity from the
ambiguous HLA data [36] and use the generated high-resolution HLA alleles in learning
the SNP-based prediction method (Figure 4.1). However, depending on the levels of
ambiguity in the HLA data, the errors generated by these methods can be prohibitively
high, up to 45% (this error includes the error in both, allele and phase assignment, and
should be interpreted as the upper bound on the allele assignment error) [36]. These
errors are then further propagated when the incorrectly imputed HLA alleles are used
to train the SNP-based prediction model.
In our previous work we proposed a method to infer HLA alleles from SNP geno-
types and population HLA haplotype frequencies [53, 54]. We used an expectation-
maximization (EM) based approach to assign the most likely HLA assignment to a new
test sample. In this chapter we propose an approach that utilizes ambiguous HLA data
in SNP-based prediction. The contributions of this chapter are the following:
(a) We propose a novel approach to SNP-based prediction of HLA alleles that handles
not only phase ambiguity, but also allele ambiguity in the HLA genotypes, and thus
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uses ambiguous HLA data as a learning source in the prediction (Figure 4.1).
(b) Additionally, we evaluate how different levels of ambiguity in HLA data impact the
prediction performance.
(c) Finally, we demonstrate that building the predictive model from ambiguous, rather
than from statistically imputed high-resolution data, is a more accurate approach
to SNP-based prediction of HLA alleles.
4.2 Methods: Amb-EM Algorithm
Here we describe Amb-EM, a novel approach to predicting HLA alleles from SNP data
by using EM to resolve allele and phase ambiguity in the training data. This approach
builds upon our previous work described in [54]. The novelties of Amb-EM are described
in Section 4.2.1, while Section 4.2.2 is briefly summarized from [54].
4.2.1 Step 1: Independent EM classifiers
Classifiers are trained for each gene separately using SNPs within and around that gene,
that is, to classify HLA-A alleles, we use SNPs within and around HLA-A only, and
so on. We first use the EM to model the joint distribution of SNP and HLA alleles
by estimating the frequency of their joint (SNP, HLA) haplotypes, and then use Bayes’
rule to compute the probability of all pairs of HLA alleles given a new sample with SNP
genotype data.
Training
Given ambiguous HLA and SNP genotypes for all samples in the training data set, EM
estimates the frequencies of all haplotypes that could be obtained from the data. The
outcome is a set of joint (SNP,HLA) haplotypes h and their estimated frequencies f .
To do this, the EM algorithm expands the un-phased genotype data into all possible
phased pairs of haplotypes. For instance, given four SNPs s = (AT,GG,CT, TT ), all
possible pairs of haplotypes that could be obtained from this data are:
s = (AT,GG,CT, TT ) → h1 = A G C T, h2 = T G T T
h1 = A G T T, h2 = T G C T
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where h1 and h2 are the two haplotypes.
In this example, the SNP genotype data only contains phase ambiguity, that is, the
exact allele assignments are known at each SNP. In addition to phase ambiguity, HLA
data often contains allele ambiguity as well. For example, an individual’s typing at gene
HLA-A may result in two ambiguous alleles g1 and g2, where g1 is either A ∗ 01 : 01
or A ∗ 01 : 02 and g2 is one of the following three alleles: A ∗ 25 : 13, A ∗ 26 : 01,
A ∗ 26 : 52. All possible HLA-A genotypes are therefore all possible combinations of g1
and g2 ambiguities, that is
g = (g1; g2) = (A∗01 : 01, A∗01 : 02; A∗25 : 13, A∗26 : 01, A∗26 : 52)→
A ∗ 01 : 01, A ∗ 25 : 13
A ∗ 01 : 01, A ∗ 26 : 01
A ∗ 01 : 01, A ∗ 26 : 52
A ∗ 01 : 02, A ∗ 25 : 13
A ∗ 01 : 02, A ∗ 26 : 01
A ∗ 01 : 02, A ∗ 26 : 52
where g is ambiguous HLA typing at gene HLA−A. A comma is used to separate HLA
allelic ambiguities, while a semi-colon is used to separate a pair of HLA alleles on the
two chromosomes.
With each HLA ambiguity, the number of possible phased pairs of (SNP, HLA)
haplotypes increases exponentially. For example, given three SNPs, s = (AT,GG,CT ),
and two ambiguities at geneHLA−A, g = (A∗01 : 01, A∗01 : 02; A∗26 : 01, A∗26 : 52),
the number of possible (SNP, HLA) haplotype pairs is n = 16, that is
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(s, g) = (AT,GG,CT,A∗01 : 01, A∗01 : 02;A∗26 : 01, A∗26 : 52)→
A G C A ∗ 01 : 01, T G T A ∗ 26 : 01
A G C A ∗ 01 : 01, T G T A ∗ 26 : 52
A G C A ∗ 01 : 02, T G T A ∗ 26 : 01
A G C A ∗ 01 : 02, T G T A ∗ 26 : 52
T G T A ∗ 01 : 01, A G C A ∗ 26 : 01
T G T A ∗ 01 : 01, A G C A ∗ 26 : 52
T G T A ∗ 01 : 02, A G C A ∗ 26 : 01
T G T A ∗ 01 : 02, A G C A ∗ 26 : 52
A G T A ∗ 01 : 01, T G C A ∗ 26 : 01
A G T A ∗ 01 : 01, T G C A ∗ 26 : 52
A G T A ∗ 01 : 02, T G C A ∗ 26 : 01
A G T A ∗ 01 : 02, T G C A ∗ 26 : 52
T G C A ∗ 01 : 01, A G T A ∗ 26 : 01
T G C A ∗ 01 : 01, A G T A ∗ 26 : 52
T G C A ∗ 01 : 02, A G T A ∗ 26 : 01
T G C A ∗ 01 : 02, A G T A ∗ 26 : 52
This number is a power of 2 larger than the number of haplotype pairs in the case of no
ambiguities at the gene A. For example, for the same three SNPs and non-ambiguous
HLA-A alleles, g = (A ∗ 01 : 01; A ∗ 26 : 01), the number of possible haplotype pairs is
n = 4, that is
(s, g) = (AT ;GG;CT ;A ∗ 01 : 01, A ∗ 26 : 01)→
A G C A ∗ 01 : 01, T G T A ∗ 26 : 01
T G T A ∗ 01 : 01, A G C A ∗ 26 : 01
A G T A ∗ 01 : 01, T G C A ∗ 26 : 01
T G C A ∗ 01 : 01, A G T A ∗ 26 : 01
Now, given a sequence of un-phased SNP genotypes and ambiguous un-phased HLA
genotypes, EM expands the sequence into all possible pairs of haplotypes and collects
all unique (SNP, HLA) haplotypes. It then iterates between pairs of (SNP, HLA) hap-
lotypes and a set of (SNP, HLA) haplotypes observable from the data, in the following
manner:
• Expectation - uses current haplotype frequencies to calculate conditional proba-
bilities of each possible pair of haplotypes given the observed SNP and HLA data
for each subject. These are then used to update current frequencies of each pair
of haplotypes.
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• Maximization - uses the frequencies of pairs of haplotypes from the previous step
to update haplotype frequencies. In the initial step, haplotype frequencies are set
to 1/nh where nh is the number of unique haplotypes in the data set.
These two steps are repeated until estimated frequencies do not change or the pre-set
number of iterations is exceeded. The outcome is a set of joint (SNP,HLA) haplotypes
h that agree with the observed genotype data in the training sample and their esti-
mated frequencies f(ga, sa1 , sa2 , ..., sam) where sa and ga denote a SNP and HLA allele
respectively, and m is the number of SNPs.
Prediction
Let gi = (gi1, gi2) denote an HLA genotype of subject i and si = (sij ,∀j ∈ [1,m])
represent a SNP genotype. Let sa denote a SNP allele, and ga an HLA allele. Given
haplotype frequencies f(ga, sa1 , sa2 , ..., sam) estimated in the previous step by EM, and
a new sample with a SNP genotype s′ = (s′j , ∀j ∈ [1,m]), the probability that this
sample has any two HLA alleles g = (g1, g2) can be calculated as follows:
P (g|s′) ∝ P (g, s′) (4.2.1)
where P (g, s′) = P (g1, g2, s′) is a joint probability of HLA and SNP genotypes,
and can be obtained by summing the frequencies over the set H of all (HLA,SNP )
haplotypes that can be generated from that genotype:
P (g, s′) = P (g1, g2, s1, s2, ..., sm) =
∑
H
f(g1, sa11 , sa21 , ..., sam1)∗f(g2, sa12 , sa22 , ..., sam2).
(4.2.2)
The top predicted HLA allele pair for a new SNP genotype s′ is that for which the
probability P (g|s′) is maximal:
(g′1, g
′
2) = arg max
(g1,g2)
P ((g1, g2)|s′). (4.2.3)
An example of expanding a new SNP genotype s′ and an allele pair g = (A ∗ 01 :
01, A∗02 : 50) into all possible pairs of haplotypes and computing their joint probability
is shown in Chapter 2 in Figure 2.5.
We assign a prediction score to each of the two selected alleles to obtain an allele
score as follows:
Sg′1 = Sg′2 = P ((g1, g2)|s′) (4.2.4)
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We use these scores along with HLA haplotype frequencies in gene-dependent prediction
described next.
4.2.2 Step 2: Correlated prediction using HLA haplotype frequencies
Top predictions
Instead of keeping only the first allele pair predicted by EM classifiers for each HLA gene,
we keep several top predictions by sorting them in descending order of their prediction
likelihood. We then move down the list until the cumulative prediction likelihood ex-
ceeds a prespecified threshold, and keep the visited predictions. We obtain top predicted
allele pairs for each sample in the testing data and for all HLA genes independently.
HLA haplotype frequencies
Given a set of likely predictions at each gene, we use population haplotype frequencies
[20] to narrow down the selection of HLA alleles and make final predictions. The
haplotype frequencies are estimated at the level of the entire US population and inform
us of how likely sets of alleles are to co-occur in each separate population [20]. We utilize
the structure that exists between the genes as an additional source of information in
order to improve the prediction.
We do this in the following manner: given a set of selected allele pairs for each
gene, we generate all possible pairs of HLA haplotypes. Let’s call this set H. Given a
haplotype frequency table constructed from the population haplotype frequencies, we
retrieve the frequency of each HLA haplotype from H and assign a haplotype score to
each pair of haplotypes by multiplying their respective frequencies.
To select the most likely pair of haplotypes for a test sample with unknown HLA
alleles, we combine the allele prediction score obtained by EM, SA, and the haplotype
score obtained in this step, SH , into a weighted score S as follows:
S = (1− δ) ∗ SA + δ ∗ SH (4.2.5)
where δ ∈ [0, 1]. The predicted pair of haplotypes for a new sample is the one with
the highest score S. For small δ, predictions are based more heavily on independently
obtained allele score SA and less on haplotype score SH , and vice versa.
The entire method is shown in Algorithm 2.
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Algorithm 2 Amb-EM
for each new sample s do
Construct modified EM classifier for each gene
Find top predictions for s for each gene
Assign prediction likelihoods as allele scores of top allele pairs
Using top predictions, generate all possible pairs of HLA haplotypes
Retrieve haplotype frequency for candidate haplotypes
Compute a score that combines allele and haplotype scores
Determine a pair of haplotypes such that the overall score is maximized
end for
4.3 Results and Discussion
4.3.1 Experimental goals
We conducted several experiments to evaluate the performance of our proposed approach
on a real world data set. More specifically, we explored the following research questions:
• Is it better to incorporate allelic ambiguity straight into the model or to resolve
the ambiguity through statistical imputation before building the model? We inves-
tigated this question by comparing the results obtained by running Amb-EM on
the ambiguous data and the results obtained by running our previous method that
does not handle ambiguity on data imputed to high-resolution. (Section 4.3.3).
• How do different amounts of ambiguity in the training data impact the prediction
performance? We varied the level of ambiguity in the training data and compared
the obtained accuracies for each ambiguity level (Section 4.3.4).
We use accuracy, as the percentage of correctly predicted alleles, as the evaluation metric
in all experiments. Section 4.3.2 describes the data sets used in this study.
4.3.2 Data sets
We used HLA and SNP data from the 1000 Genomes project (KG)9 . This data set
contains 930 individuals as summarized in Table 4.1. The 1000 Genomes individuals
are typed at 10, 268 SNPs in the MHC region and 5 HLA genes (HLA-A, -C, -B, -DRB1,
-DQB1).
9 http://www.1000genomes.org/
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Abbreviation Population Count Broad Count
CEPH CEPH individuals 45
FIN HapMap Finnish individuals from
Finland
93
GBR British individuals from England
and Scotland
89
TSI Toscan individuals 90 Europe
(EUR)
317
CHB+JPT Han Chinese in Beijing, Japanese in-
dividuals
165
CHS Han Chinese South 100 Asia (ASI) 265
CLM Colombian in Medellin, Colombia 60
MXL HapMap Mexicans from LA Califor-
nia
55
PUR Puerto Rican in Puerto Rico 55 Americas
(AM)
170
ASW HapMap African individuals from
SW US
53
LWK Luhya individuals 87
YRI Yoruba individuals 38 Africa
(AFR)
178
Total 930
Table 4.1: The 1000 Genome (KG) data set.
We also used SNP and HLA genotype data from the British 1958 Birth Cohort
(BC)10. Genotyping of the BC data was carried out using Illumina Human1M-Duo [7].
High resolution typing of five HLA genes (HLA-A, -C, -B, -DRB1, -DQB1) is obtained
using Sequence Specific Oligonucleotide methodology11. After processing, this data set
to include samples that have all 5 HLA genes and a high SNP overlap with the 1000
Genomes data set we, we ended up with 100 samples of European origin with all 5 HLA
genes. There are 3267 SNPs that overlap between the two data sets.
10 www.b58cgene.sgul.ac.uk
11 www-gene.cimr.cam.ac.uk/public data/HLA/HLA.shtml
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4.3.3 Prediction on ambiguous and imputed data
Here we compare the results obtained by running Amb-EM on ambiguous data with
the results obtained by running our previous method described in Chapter 2 on im-
puted high-resolution data. We aim to evaluate whether Amb-EM, which incorporates
uncertainty in HLA data straight into the SNP-based HLA prediction model, outper-
forms the model built from imputed HLA data. We trained the prediction model on a
randomly selected 80% subset of the data and tested it on the remaining 20%. Table
4.2 shows the overall accuracy of prediction using Amb-EM for each HLA gene, across
all populations, as well as the accuracy by population. Highest accuracy is achieved
on the European populations (EUR), while the worst accuracy is achieved for African
(AFR) and Hispanic (AM) populations. This result agrees with previous findings and
the expectations, since HLA genes in European populations are on average less genet-
ically diverse than in other populations, while in African populations, they are more
genetically diverse, and therefore more difficult to predict.
Table 4.2: Accuracy at 2-field resolution for all available samples with ambiguities.
δ = 0.5 Overall AFR ASI EUR AM
A 0.75 0.61 0.65 0.83 0.79
C 0.88 0.87 0.82 0.90 0.88
B 0.74 0.61 0.76 0.84 0.58
DRB1 0.73 0.56 0.77 0.83 0.56
DQB1 0.91 0.89 0.91 0.90 0.94
Table 4.3: Accuracy at 2-field resolution for all available samples with no ambiguities
(data previously imputed to high resolution).
δ = 0.5 Overall AFR ASI EUR AM
A 0.74 0.60 0.65 0.83 0.76
C 0.86 0.87 0.85 0.89 0.81
B 0.73 0.60 0.76 0.82 0.58
DRB1 0.73 0.57 0.76 0.83 0.55
DQB1 0.91 0.88 0.91 0.90 0.94
Next, we resolved the ambiguity in the training data through imputation [36] and
ran our previous method described in Chapter 2 on the resolved data. The results of
this experiment are shown in Table 4.3. On average the prediction results obtained
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by Amb-EM on ambiguous data are better than on statistically imputed data. Figure
4.2 shows the percentage change in accuracy when using ambiguous rather than the
imputed HLA data. The height of the bars indicate the improvement in accuracy of
the Amb-EM on ambiguous data over the accuracy of the old method on the imputed
data. Overall, the change in accuracy is positive when we incorporate HLA ambiguity
in the prediction model. For example, in AM populations, the accuracy at gene HLA-C
is increased by as much as 7%. Incorporating the HLA ambiguity into the prediction
process avoids the error that comes from imputing high-resolution HLA alleles from
ambiguous HLA data, and using them in the prediction process.
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Figure 4.2: Percentage change in accuracy when using Amb-EM on ambiguous data
over the accuracy of the old method [54] on the imputed data.
The results, however, were not conclusive. We ran a 5-fold cross-validation on the
same data, where we divided the data set into 5 folds, using in turn, 1 out of 5 folds for
testing and the remaining folds for training. Figure 4.3 shows median (blue bars) and
25th and 75th percentiles (red lines) of the change in accuracy measured in percentages.
While the median change in accuracy for genes HLA-A, HLA-C and HLA-B is positive,
the change in accuracy for genes HLA-DRB1 and HLA-DQB1 is negative and equal
to zero, respectively. One of the reasons for the the poor performance at these two
genes is that our data set contains relatively little ambiguity at these two genes. Gene
HLA-DRB1 has almost no uncertainty across the data set, with the average number
of ambiguous alleles equal to 1.08 per sample. Gene HLA-DQB1 has slightly higher
average number of ambiguous alleles (equal to 1.92), but still lower than the number of
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ambiguous alleles for other genes. With such high resolution data for these two genes,
the HLA imputation algorithm most likely performs well and predicts correct alleles.
On the other hand, training Amb-EM on ambiguous data introduces some error, which
is reflected in poorer performance of our method.
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Figure 4.3: Percentage change in accuracy when using Amb-EM on ambiguous data over
the accuracy of the old method [54] on the imputed data using 5-fold cross validation.
Another thing to note is that each population in our data set is represented by a
relatively low sample size. To adequately represent the existing genetic diversity in the
HLA region, many more samples are needed. The increased sample size is likely to be
beneficial to the SNP-based prediction of HLA alleles, while it does not change the result
of the statistical HLA imputation, as it is a deterministic process. This means that, in
the case of an increased sample size, the accuracy of prediction from ambiguous HLA
data and SNPs will increase, while the imputed HLA data will remain the same, and
the increased sample size will have no effect on consequent SNP-based prediction. To
demonstrate the sample size effect on our method we randomly selected 80% of the data
for training and 20% for testing. We then fixed the test samples, and varied the size of
training, by randomly sampling 1/3, 2/3, and 3/3 of the training data for training three
different models. Figure 4.4 demonstrates that as we increase the training sample size
the accuracy of prediction improves. The difference in performance of using ambiguous
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data directly in training rather then imputing it first is, therefore, likely to be even more
striking on a larger data set.
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Figure 4.4: The effect of sample size on the prediction performance of Amb-EM
4.3.4 Prediction from different levels of ambiguity in training data
In this section we investigate how different levels of ambiguity in the training data impact
the prediction performance of Amb-EM. We vary the level of ambiguity in the training
data and calculate the accuracy on the test data. Due to computational demands of
running the experiments on the entire data set, we used a subset of the data of European
ancestry for this evaluation (317 European samples from the KG data set and 100 BC
samples).
We created three different data sets by selecting 20% of the data for testing and
80% for training in the following manner:
• HR-train (high-resolution training) - samples with low allele ambiguity across all
genes are selected for training
• R-train (random training) - data randomly split into training and testing
• LR-train (low-resolution training) - samples with high allele ambiguity across all
genes are selected for training
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Table 4.4: Accuracy at 2-field resolution for different levels of ambiguity in training
data.
LR-
train
R-train HR-
train
A 0.801 0.867 0.952
C 0.705 0.849 0.934
B 0.705 0.849 0.843
DRB1 0.801 0.819 0.747
DQB1 0.843 0.910 0.916
The obtained accuracies at 2-field resolution data and for δ = 0.5 for all three data
sets are shown in Table 4.4. In general the highest accuracy is obtained for the HR-
train data set, that is, the data set with the lowest level of ambiguity in the training
data. This is expected, since the uncertainty in the training data introduces some error
into the prediction model. Figure 4.5 shows that the biggest increase in accuracy as
the ambiguity in training decreases is seen at genes HLA-A and -C. However, for other
genes, we do not see a clear increasing trend in accuracy as the ambiguity in training
decreases. This is due to the varying levels of ambiguity across different genes, because
the training and testing data for the three scenarios are selected based on the overall
number of ambiguous genotypes across all genes, rather than individual genes.
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Figure 4.5: Figure on the left shows the accuracy achieved on the test data for different
levels of ambiguity in the training data. The Figure on the right shows the count of
ambiguous genotypes in the training data for all three cases: HR-train, R-train, and
LR-train.
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For example, there is less difference in ambiguity levels within genes HLA-DRB1 and
-DQB1 in the three scenarios, than within genes HLA-A and -C. This is demonstrated
in the Figure 4.5, where the right plot shows the count of ambiguous genotypes in the
training data for each gene. The height of the bars corresponds to the median and the
lines mark the 25th and 75th percentile of the count. Notice that genes HLA-A, -C,
and -B contain the most ambiguity in the training, while there are very few ambiguous
genotypes at genes HLA-DRB1 and -DQB1. Gene HLA-DRB1 also contains ambiguous
samples but they do not fall into the 75th percentile. Given similar levels of ambiguity
at genes DRB1 and DQB1 in the three scenarios, the variation in accuracy comes from
the allele variation in the training and testing samples. This result also demonstrates
that for low levels of ambiguity the loss in prediction accuracy is not significant and that
the performance of Amb-EM is comparable to the performance of our previous method
on imputed high-resolution HLA data.
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Figure 4.6: Analysis of errors for HLA-A alleles. Blue bars show a count of alleles in
the training data set (left y-axis). Black and brown bars represent the count of errors
(incorrect predictions) and the count of true alleles that were incorrectly predicted in the
test data set, respectively (right y-axis). Note that left and right y-axis have different
scales.
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Figure 4.7: Analysis of errors for HLA-C alleles. Blue bars show a count of alleles in
the training data set (left y-axis). Black and brown bars represent the count of errors
(incorrect predictions) and the count of true alleles that were incorrectly predicted in the
test data set, respectively (right y-axis). Note that left and right y-axis have different
scales.
Additionally, we took a closer look at the errors predicted by our method in order
to identify factors influencing its performance. Since the HLA alleles are not uniformly
distributed in a population, some alleles may be more difficult to predict than the others.
More specifically, rare alleles that occur with a very low frequency in a sample will be
more challenging to predict than the ones that occur very frequently. We showed this in
our data by looking at the distribution of the errors predicted by our method and their
occurrence in the training sample. We randomly selected 80% of the data for training
and 20% of the data for testing. Figures 4.6, 4.7, 4.8, 4.9, and 4.10 show alleles that
were incorrectly predicted for HLA-A, -C, -B, -DRB1, and DQB1 genes, respectively,
and their occurrence count in the training sample. Blue bars in the figures represent
allele frequencies in the training data set. For a given allele: black bars represent those
alleles in the test set that were predicted to be the given allele but are not, while brown
bars represent those alleles in the test set whose type is that of the given allele that were
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Figure 4.8: Analysis of errors for HLA-B alleles. Blue bars show a count of alleles in
the training data set (left y-axis). Black and brown bars represent the count of errors
(incorrect predictions) and the count of true alleles that were incorrectly predicted in the
test data set, respectively (right y-axis). Note that left and right y-axis have different
scales.
predicted to be a different allele. For example, in Figure 4.7, there are two HLA-C*07:02
alleles in the testing set that were incorrectly predicted as different alleles, and there is
one allele in the testing set that is predicted as HLA-C*04:01 but is truly a different
allele. The alleles are sorted in the descending order of their frequency in the training
sample.
In general, the lower the frequency of an allele in the training data set, the more
likely it is to be incorrectly predicted if found in the test data set. For example, alleles
HLA-A*24:24 (Figure 4.6) and HLA-C*03:36 (Figure 4.7) do not occur at all in the
training sample, and therefore, cannot be correctly predicted in the test sample. Other
alleles, like HLA-DRB1*14:05 (Figure 4.9) and HLA-DQB1*03:04 (Figure 4.10) occur
in the training sample, but with a low frequency. On the other hand, there are alleles
that occur with a relatively high frequency in the training data and still occur as errors.
These incorrect predictions could be attributed to the population diversity in our data.
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Figure 4.9: Analysis of errors for HLA-DRB1 alleles. Blue bars show a count of alleles
in the training data set (left y-axis). Black and brown bars represent the count of errors
(incorrect predictions) and the count of true alleles that were incorrectly predicted in the
test data set, respectively (right y-axis). Note that left and right y-axis have different
scales.
We used all of the data in this evaluation (KG and BC samples) in order to increase
the sample size. However, building separate models for each distinct population in the
sample may be a better approach and a way to avoid errors of this type. Another impact
of the population heterogeneity can be seen around the incorrect predictions that are
most often made (black bars in the figures). For example, most of the true alleles that
are incorrectly predicted for HLA-A gene are predicted into the allele HLA-A*02:01.
This allele has the highest frequency for European populations12(Figure 4.6). The same
is true for alleles HLA-C*05:01, HLA-B*35:01, HLA-DRB1*08:01, HLA-DQB1*06:02
(Figure 4.7, 4.8, 4.9, 4.10, respectively). As European sample is the largest in our data
(417 total samples in KG and BC data sets) the incorrect predictions tend to gravitate
towards alleles most frequent in this population.
We also discovered, as a result of this evaluation, that incorrectly predicted alleles
12 http://www.pypop.org/popdata/
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Figure 4.10: Analysis of errors for HLA-DQB1 alleles. Blue bars show a count of alleles
in the training data set (left y-axis). Black and brown bars represent the count of errors
(incorrect predictions) and the count of true alleles that were incorrectly predicted in the
test data set, respectively (right y-axis). Note that left and right y-axis have different
scales.
tend to get predicted into the same allele family (1-field group). For example, all
samples with incorrectly predicted allele HLA-A*02:01 (black bars in Figure 4.8) have
one of the following true alleles: HLA-A*02:02, A*02:03, A*02:05, A*02:06, A*02:07,
A*02:11, A*02:14, A*02:20. Similarly, all samples with the incorrectly predicted allele
HLA-A*68:01 have A*68:02 as a true allele. Some of the reasons for this type of error is
either the lack of the SNPs to distinguish between the different alleles within the same
allele family, or the inability of our method to capture those differences.
4.4 Conclusion
In this chapter we proposed a SNP-based approach for prediction of HLA alleles that
utilizes ambiguous HLA genotypes as a learning source when building the predictive
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model. Additionally, we evaluated how different levels of ambiguity in HLA data im-
pact the prediction performance and concluded that small levels of ambiguity do not
significantly decrease the prediction accuracy. Finally, we showed that building the pre-
dictive model from ambiguous, rather than from statistically imputed high-resolution
data, is a better approach to SNP-based prediction of HLA alleles. This is particularly
true for non-European populations for which the HLA imputation error is larger than
for a European population [36]. We showed that the loss of information due to the
ambiguity in the training HLA data is smaller than the loss of information due to error
incurred from HLA imputation.
As a future direction we intend to apply this approach on a larger sample and
investigate whether the increased sample size can compensate for the loss of information
due to the ambiguous HLA data. SNP-based prediction of HLA is highly dependent on
the sample size because of the genetic diversity of HLA genes. Small samples do not have
a good representation of the alleles in a population and tend to result in lower prediction
accuracies. We believe that larger sample would compensate for the uncertainty in the
data and result in a performance that would be comparable to the performance on the
non-ambiguous data of the same size. Additionally, in order to avoid the errors within an
allele family described in the previous section, we intend to implement a SNP selection
step prior to building the model. This step would intelligently select the SNPs that are
best able to distinguish alleles in the same allele family and, in general, as many alleles
as possible in a validation data set.
Chapter 5
Conclusion and Discussion
This thesis addressed the challenges of prediction and analysis of HLA data. First,
we defined a problem of prediction of HLA genes from SNP markers and described a
two-step multi-label multi-class approach that utilizes strong correlations among labels
to solve it [53, 54]. Second, we addressed the challenge of quantifying the uncertainty in
HLA typing data, and demonstrated that the strong correlation structure is informative
when it comes to resolving this uncertainty [52]. Third, we devised an approach to
learning from uncertain HLA data in the SNP-based prediction of HLA genes that
incorporates the uncertainty into the model [55]. In this chapter, we summarize the
key results and provide an outlook of future work in this area.
5.1 Key Results
This section presents a summary of the major results that were produced as a part of
this thesis.
5.1.1 Correlated multi-label multi-class prediction
We presented a novel approach for correlated multi-label multi-class prediction in the
context of SNP-based prediction of HLA genes [53, 54]. Each HLA gene is a multi-class
label. Labels are correlated because of the strong linkage disequilibrium in this region.
We proposed a two step approach to predict HLA genes from SNPs that uses structural
information that exists in the HLA region. In the first step we build label-independent
88
89
classifiers based on the Expectation-Maximization algorithm. In the second step we
use HLA haplotype frequencies to enforce the correlation between labels and to make
the final prediction. We demonstrated that adding haplotype frequency information
increases the accuracy of prediction.
In addition, we evaluated the impact of HLA gene dependency on the prediction of
HLA genes from SNP data [54]. We proposed integrating local and global dependencies
among HLA genes into the prediction, and evaluated the impact of both approaches.
Our results showed that the addition of global structure produces a more robust predic-
tion with respect to the algorithm’s parameter. However, given the small sample size of
our data and a lack of population diversity, we expect that the local structure approach
may have different impact in a larger data set or a data set of non-European origin.
Large data sets are more likely to contain rare alleles, and strong local dependencies
would be able to promote prediction ranking for these alleles. Additionally, haplotype
patterns differ across populations. It has been observed that African haplotypes are
shorter than non-African haplotypes, which implies that local structure should be more
beneficial to prediction on data sets of African ancestry.
5.1.2 Quantifying uncertainty in HLA data
The high polymorphism in HLA presents a challenge when it comes to typing or sequenc-
ing HLA genes.The typing of HLA alleles is generally performed using DNA-based assays
that are not always able to precisely identify alleles present. Exact allele-level HLA typ-
ing can be costly and laborious with the large and rapidly growing number of described
HLA alleles. We described an information-theory based measure to quantify ambiguity
content in an HLA typing [52]. We demonstrate that it can be objectively used to com-
pare methods of HLA typing to each other in terms of the information they provide, in
the context of each individual population. Our results show that intermediate-resolution
single-pass sequence-based typing contains the least ambiguity and, therefore, the most
certainty in allele prediction across all populations. In addition, we demonstrated the
benefit of using haplotype frequencies in entropy calculations versus allele frequencies.
When certain alleles occur together generally due to linkage disequilibrium between
them, some ambiguity can be inferred away using this linkage information, which is
inherently contained in haplotype frequencies. Our results show that using population
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haplotype frequencies immensely reduces the ambiguity present in HLA typing.
5.1.3 Learning from uncertain data
We described a novel algorithm for prediction of uncertain data in the context of SNP-
based prediction of HLA genes [55]. The existing uncertainty found in most HLA data
sets today presents a challenge to current SNP-based methods for prediction of HLA
alleles, since they require non-ambiguous data. While the typing methodology evolved
over time and will evolve further, the majority of a stem-cell registry data still consists
of ambiguous HLA assignments [20]. The Be The Match registry contains HLA typing
of approximately 10 million donors as of this year, and the majority of these donors
have ambiguous HLA data. In order to utilize the large amounts of historical HLA data
in the Registry operations or research, we must develop algorithms that can successfully
learn from uncertain data.
A way to obtain high-resolution HLA alleles from ambiguous data is to use one of
the existing methods for resolving ambiguity from the ambiguous HLA data [36] and use
the generated high-resolution HLA alleles in learning the SNP-based prediction method
(Figure 4.1). However, depending on the levels of ambiguity in the HLA data, the
errors generated by these methods can be prohibitively high. These errors are then
further propagated when the incorrectly imputed HLA alleles are used to train the
SNP-based prediction model. In this thesis we proposed a SNP-based approach for
prediction of HLA alleles that utilizes ambiguous HLA genotypes directly as a learning
source when building the predictive model. Additionally, we evaluated how different
levels of ambiguity in HLA data impact the prediction performance and concluded
that small levels of ambiguity do not significantly decrease the prediction accuracy.
Finally, we showed that building the predictive model from ambiguous, rather than
from statistically imputed high-resolution data, is generally a more accurate approach
to SNP-based prediction of HLA alleles. This is particularly true for non-European
populations for which the HLA imputation error is larger than for European population
[36]. We showed that the loss of information due to the ambiguity in the training HLA
data is smaller than the loss of information due to error incurred from HLA imputation.
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5.2 Future Directions
We plan to continue our research in the following directions:
Investigation of computational approaches to correlated multi-label predic-
tion: We intend to investigate possible improvements or alternative approaches to cor-
related multi-label multi-class prediction in the context of HLA genes. The algorithms
described in this thesis include many parameters, and we intend to conduct a thorough
experimental evaluation of how those parameters impact the overall performance of the
method. Our current implementation of the base EM classifier is computationally ex-
pensive and cannot handle large numbers of SNPs. In the future, we plan to use a
more scalable classifier that will handle larger numbers of SNPs and therefore make
better initial predictions of HLA alleles. Another potential direction for improvement
is the function to combine allele and haplotype scores into a final score. We currently
use a weighted sum, however, we intend to investigate several other functions and their
impact on prediction performance of the algorithm.
In this thesis we used haplotype frequencies published in [37] and generated from
a relatively small sample of about 10K (compared to the current ∼ 10M) individuals.
In the future we intend to use more recently published haplotype frequencies generated
from a much larger sample size (∼ 6M individuals) and encompassing more populations
(21 detailed populations) [20]. Using these frequencies may result in higher accuracies
as they more adequately represent a population (e.g. using African Black population
frequencies published in [20] may enhance predictions for YRI population used in this
study because they match the YRI population more closely than African American
frequencies published in [37]).
Finally, we intend to investigate different approaches to the implementation of gene-
independent classifiers for the Step 1 of the algorithms described in Chapters 2 and 4.
Recent methods for independent prediction of HLA genes from SNP data have demon-
strated high accuracies [12, 85]. We plan to investigate how integrating some of these
alternative methods into our framework impact the prediction performance.
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Investigate the impact of the sample diversity: We plan to investigate the ap-
plication of the proposed prediction framework on a data set of non-European origin.
As demonstrated in the BC data set in Chapter 2, there is little room for improvement
on large data sets of European origin, since high accuracies are obtained even without
the addition of HLA haplotype information. However, data sets of non-European ori-
gin are less widely available, generally available at smaller sample size and have higher
genetic diversity. As such, they present a bigger challenge when it comes to prediction
of HLA genes and could greatly benefit from the gene dependency information. In ad-
dition, linkage disequilibrium patterns differ in different populations, and the addition
of dependency information into the HLA prediction may be even more beneficial for a
non-European population.
Additionally, we intend to investigate the impact of the sample size on the perfor-
mance of our Amb-EM algorithm, in order to measure whether the increased sample size
can compensate for the loss of information due to the ambiguous HLA data. SNP-based
prediction of HLA is highly dependent on the sample size because of the genetic diver-
sity of HLA genes. Small samples do not have a good representation of the alleles in a
population and tend to result in lower prediction accuracies. We believe that a larger
sample would compensate for the uncertainty in the data and result in a performance
that would be comparable to the performance on the non-ambiguous data of the same
size.
Prediction of haplotypes: An additional advantage of our approach for prediction
of HLA alleles proposed in Chapter 2 is that it can be used for prediction of HLA
haplotypes, rather than individual genes. Our algorithm can be extended to return a
ranked list of HLA haplotypes that a new sample is likely to have. This is valuable
in the context of stem cell transplant where donor search is performed based on sev-
eral highest ranking haplotype pairs imputed from the ambiguous HLA data. It has
also been shown that haplotype matching can inform on the graft-versus-host disease
post transplant among HLA-identical transplant recipients [56]. We intend to extend
our algorithm to predict phased HLA haplotypes for a new sample, and evaluate its
performance on a sample with phased HLA data (such as the family data from the
International Project HapMap [17]). Prediction of haplotypes rather than individual
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HLA genes is more challenging due to the increased complexity of the problem.
Further investigation of data uncertainty: We plan to further investigate different
approaches to learning from uncertain data. Our approach presented in Chapter 4
of this thesis incorporates all of the uncertainty present in the data into building the
prediction model. We intend to investigate whether some of the uncertainty in the data
can be resolved and removed before building the model without performance loss. The
measure we introduced in Chapter 3 for quantifying the uncertainty in HLA data could
be applied on uncertain data as the first step in attempt to remove the unlikely HLA
uncertainties, and keep only the ones that will be informative for the prediction, rather
than introduce noise.
Additionally, we aim to explore new ways for quantifying typing ambiguity that
will be more intuitive and comparable across different system. We plan to differenti-
ate between the content of ambiguity present in HLA genotypes and HLA un-phased
genotypes, that has a more practical application in the context of donor and patient
matching. Finally, we aim to analyze the HLA typing data in the Be The Match R©
registry using the improved ambiguity measure and demonstrate its value to other stem
cell registries and HLA typing labs.
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